| Year |
Citation |
Score |
| 2005 |
Thomas MJ, Mameli M, Carta M, Valenzuela CF, Li PK, Partridge LD. Neurosteroid paradoxical enhancement of paired-pulse inhibition through paired-pulse facilitation of inhibitory circuits in dentate granule cells. Neuropharmacology. 48: 584-96. PMID 15755486 DOI: 10.1016/J.Neuropharm.2004.11.014 |
0.444 |
|
| 2001 |
Sutherland RJ, Weisend MP, Mumby D, Astur RS, Hanlon FM, Koerner A, Thomas MJ, Wu Y, Moses SN, Cole C, Hamilton DA, Hoesing JM. Retrograde amnesia after hippocampal damage: recent vs. remote memories in two tasks. Hippocampus. 11: 27-42. PMID 11261770 DOI: 10.1002/1098-1063(2001)11:1<27::Aid-Hipo1017>3.0.Co;2-4 |
0.464 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2005 |
Laing E, Grant J, Thomas M, Parmigiani C, Ewing S, Karmiloff-Smith A. Love is... an abstract word: the influence of lexical semantics on verbal short-term memory in Williams syndrome. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 41: 169-79. PMID 15714899 DOI: 10.1016/S0010-9452(08)70891-8 |
0.221 |
|
| 2022 |
Metzenmacher M, Griesinger F, Hummel HD, Elender C, Schäfer H, de Wit M, Kaiser U, Kern J, Jänicke M, Spring L, Zacharias S, Kaiser-Osterhues A, Groth A, Hipper A, Zaun G, ... ... Thomas M, et al. Prognostic factors in non-small-cell lung cancer: insights from the German crisp registry. The European Respiratory Journal. PMID 36180086 DOI: 10.1183/13993003.01336-2022 |
0.147 |
|
| 2022 |
Bozorgmehr F, Christopoulos P, Chung I, Cvetkovic J, Feißt M, Krisam J, Schneider MA, Heußel CP, Kreuter M, Müller DW, Thomas M, Rieken S. Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial. Bmc Cancer. 22: 1011. PMID 36153496 DOI: 10.1186/s12885-022-10074-9 |
0.143 |
|
| 2023 |
Mazieres J, Paik PK, Garassino MC, Le X, Sakai H, Veillon R, Smit EF, Cortot AB, Raskin J, Viteri S, Wu YL, Yang JCH, Ahn MJ, Ma R, Zhao J, ... ... Thomas M, et al. Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial. Jama Oncology. PMID 37270698 DOI: 10.1001/jamaoncol.2023.1962 |
0.141 |
|
| 2022 |
Chouaid C, Thomas M, Debieuvre D, Durand-Zaleski I, Zacharias S, Bosquet L, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, Carroll R, Waldenberger D, et al. Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers. 14. PMID 36551632 DOI: 10.3390/cancers14246148 |
0.14 |
|
| 2019 |
Bozorgmehr F, Hommertgen A, Krisam J, Lasitschka F, Kuon J, Maenz M, Huber PE, König L, Kieser M, Debus J, Thomas M, Rieken S. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial. Bmc Cancer. 19: 1074. PMID 31703637 DOI: 10.1186/s12885-019-6205-0 |
0.139 |
|
| 2024 |
Richtmann S, Marwitz S, Muley T, Koistinen H, Christopoulos P, Thomas M, Kazdal D, Allgäuer M, Winter H, Goldmann T, Meister M, Klingmüller U, Schneider MA. The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 38490536 DOI: 10.1016/j.trsl.2024.02.007 |
0.138 |
|
| 2024 |
Houda I, Dickhoff C, Uyl-de Groot CA, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe. The Lancet Regional Health. Europe. 38: 100840. PMID 38476748 DOI: 10.1016/j.lanepe.2024.100840 |
0.137 |
|
| 2022 |
Janke F, Angeles AK, Riediger AL, Bauer S, Reck M, Stenzinger A, Schneider MA, Muley T, Thomas M, Christopoulos P, Sültmann H. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients. Clinical Epigenetics. 14: 163. PMID 36461127 DOI: 10.1186/s13148-022-01387-4 |
0.136 |
|
| 2012 |
Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A, Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JE, Papai ZS, Karaseva N, Thongprasert S, Portulas ED, von Pawel J, et al. Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2070-8. PMID 22564989 DOI: 10.1200/Jco.2011.39.2993 |
0.136 |
|
| 2022 |
Kunz J, Wiedemann C, Grosch H, Kriegsmann K, Gryzik S, Felden J, Hundemer M, Seker-Cin H, Stenzinger M, Leo A, Stenzinger A, Thomas M, Christopoulos P. Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving Alectinib. Cancers. 14. PMID 35681698 DOI: 10.3390/cancers14112720 |
0.136 |
|
| 2015 |
Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, Spraggins J, Van de Plas R, Dehairs J, Wouters J, Bagadi M, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. International Journal of Cancer. Journal International Du Cancer. 137: 1539-48. PMID 25784292 DOI: 10.1002/Ijc.29517 |
0.136 |
|
| 2017 |
Sparla A, Flach-Vorgang S, Villalobos M, Krug K, Kamradt M, Coulibaly K, Szecsenyi J, Thomas M, Gusset-Bährer S, Ose D. Reflection of illness and strategies for handling advanced lung cancer - a qualitative analysis in patients and their relatives. Bmc Health Services Research. 17: 173. PMID 28253884 DOI: 10.1186/s12913-017-2110-x |
0.135 |
|
| 2022 |
Faltus C, Lahnsteiner A, Barrdahl M, Assenov Y, Hüsing A, Bogatyrova O, Laplana M, Johnson T, Muley T, Meister M, Warth A, Thomas M, Plass C, Kaaks R, Risch A. Identification of as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International Journal of Molecular Sciences. 23. PMID 36142605 DOI: 10.3390/ijms231810699 |
0.135 |
|
| 2020 |
Langer CJ, Gajra A, Gridelli C, Konduri K, Morgensztern D, Spigel D, Talbot D, Thomas M, Weiss J, Pilot R, Bhore R, Wolfsteiner M, Ong TJ, Socinski M. -Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis. Frontiers in Oncology. 10: 485587. PMID 33575203 DOI: 10.3389/fonc.2020.485587 |
0.135 |
|
| 2021 |
Eichhorn F, Klotz LV, Kriegsmann M, Bischoff H, Schneider MA, Muley T, Kriegsmann K, Haberkorn U, Heussel CP, Savai R, Zoernig I, Jaeger D, Thomas M, Hoffmann H, Winter H, et al. Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung Cancer (Amsterdam, Netherlands). 153: 150-157. PMID 33529989 DOI: 10.1016/j.lungcan.2021.01.018 |
0.135 |
|
| 2019 |
Dietz S, Christopoulos P, Gu L, Volckmar AL, Endris V, Yuan Z, Ogrodnik SJ, Zemojtel T, Heussel CP, Schneider MA, Meister M, Muley T, Reck M, Schlesner M, Thomas M, et al. Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK rearranged lung cancer. Cold Spring Harbor Molecular Case Studies. PMID 31753813 DOI: 10.1101/mcs.a004630 |
0.135 |
|
| 2020 |
Eichkorn T, Bozorgmehr F, Regnery S, Dinges LA, Kudak A, Bougatf N, Weber D, Christopoulos P, Muley T, Kobinger S, König L, Hörner-Rieber J, Adeberg S, Heussel CP, Thomas M, et al. Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration Rates. Frontiers in Oncology. 10: 586449. PMID 33335856 DOI: 10.3389/fonc.2020.586449 |
0.135 |
|
| 2016 |
Bernhardt D, Adeberg S, Bozorgmehr F, Opfermann N, Hoerner-Rieber J, Repka MC, Kappes J, Thomas M, Bischoff H, Herth F, Heußel CP, Debus J, Steins M, Rieken S. Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer. Clinical Lung Cancer. PMID 28027850 DOI: 10.1016/j.cllc.2016.11.012 |
0.134 |
|
| 2017 |
Schneider MA, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller NS, Theis F, Meister M. AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients. International Journal of Oncology. 50: 365-372. PMID 28101582 DOI: 10.3892/ijo.2017.3834 |
0.132 |
|
| 2024 |
Houda I, Dickhoff C, Uyl-de Groot CA, Damhuis RAM, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective. The Lancet Regional Health. Europe. 38: 100841. PMID 38476749 DOI: 10.1016/j.lanepe.2024.100841 |
0.131 |
|
| 2019 |
Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, et al. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer Immunology, Immunotherapy : Cii. PMID 30770959 DOI: 10.1007/s00262-019-02315-x |
0.131 |
|
| 2004 |
Reinmuth N, Mesters RM, Bieker R, Hoffknecht P, Berdel WE, Thomas M. Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer (Amsterdam, Netherlands). S177-86. PMID 15552798 DOI: 10.1016/j.lungcan.2004.07.976 |
0.131 |
|
| 2015 |
Ramlau R, Thomas M, Novello S, Plummer R, Reck M, Kaneko T, Lau MR, Margetts J, Lunec J, Nutt J, Scagliotti GV. Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker. Clinical Lung Cancer. PMID 25700774 DOI: 10.1016/j.cllc.2015.01.004 |
0.131 |
|
| 2020 |
Wessels S, Muley T, Christopoulos P, Meister M, Heinzmann-Groth I, Warth A, Herpel E, Hummler S, Klingmüller U, Kuon J, Heussel CP, Eberhardt R, Herth FJF, Winter H, Bischoff H, ... ... Thomas M, et al. Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives. Translational Lung Cancer Research. 9: 1000-1014. PMID 32953480 DOI: 10.21037/tlcr-20-137 |
0.131 |
|
| 2014 |
Pujol JL, Paz-Ares L, de Marinis F, Dediu M, Thomas M, Bidoli P, Corral J, San Antonio B, Chouaki N, John W, Zimmermann A, Visseren-Grul C, Gridelli C. Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Clinical Lung Cancer. 15: 418-25. PMID 25104617 DOI: 10.1016/j.cllc.2014.06.007 |
0.13 |
|
| 2017 |
Ciuleanu TE, Ahmed S, Kim JH, Mezger J, Park K, Thomas M, Chen J, Poondru S, VanTornout JM, Whitcomb D, Blackhall F. Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer. British Journal of Cancer. PMID 28772281 DOI: 10.1038/bjc.2017.226 |
0.129 |
|
| 2022 |
Griesinger F, Pérol M, Girard N, Durand-Zaleski I, Zacharias S, Bosquet L, Jänicke M, Quantin X, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, ... ... Thomas M, et al. Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. Lung Cancer (Amsterdam, Netherlands). 172: 65-74. PMID 36007281 DOI: 10.1016/j.lungcan.2022.08.001 |
0.129 |
|
| 2020 |
Kim-Wanner SZ, Assenov Y, Nair MB, Weichenhan D, Benner A, Becker N, Landwehr K, Kuner R, Sültmann H, Esteller M, Koch I, Lindner M, Meister M, Thomas M, Bieg M, et al. Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long non-coding RNA PLUT - an exploratory study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32272161 DOI: 10.1016/J.Jtho.2020.03.023 |
0.129 |
|
| 2019 |
Marwitz S, Turkowski K, Nitschkowski D, Weigert A, Brandenburg J, Reiling N, Thomas M, Reck M, Drömann D, Seeger W, Rabe KF, Savai R, Goldmann T. The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC. Frontiers in Oncology. 9: 1550. PMID 32039023 DOI: 10.3389/fonc.2019.01550 |
0.129 |
|
| 2017 |
Reck M, Paz-Ares L, Bidoli P, Cappuzzo F, Dakhil S, Moro-Sibilot D, Borghaei H, Johnson M, Jotte R, Pennell NA, Shepherd FA, Tsao A, Thomas M, Carter GC, Chan-Diehl F, et al. Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 112: 181-187. PMID 29191593 DOI: 10.1016/j.lungcan.2017.07.038 |
0.128 |
|
| 2022 |
Yaung SJ, Woestmann C, Ju C, Ma XM, Gattam S, Zhou Y, Xi L, Pal S, Balasubramanyam A, Tikoo N, Heussel CP, Thomas M, Kriegsmann M, Meister M, Schneider MA, et al. Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA. Cancers. 14. PMID 35626082 DOI: 10.3390/cancers14102479 |
0.128 |
|
| 2014 |
Schuler M, Fischer JR, Grohé C, Gütz S, Thomas M, Kimmich M, Schneider CP, Laack E, Märten A. Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib. The Oncologist. 19: 1100-9. PMID 25232040 DOI: 10.1634/theoncologist.2014-0103 |
0.127 |
|
| 2018 |
Steins M, Thomas M, Geißler M. Erlotinib. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 211: 1-17. PMID 30069756 DOI: 10.1007/978-3-319-91442-8_1 |
0.126 |
|
| 2006 |
Lange T, Müller-Tidow C, Serve H, Hoffknecht P, Berdel WE, Thomas M. First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer. Oncology Reports. 14: 1539-42. PMID 16273252 |
0.126 |
|
| 2019 |
Thomas M, Thatcher N, Goldschmidt J, Ohe Y, McBride HJ, Hanes V. Totality of evidence in the development of ABP 215, an approved bevacizumab biosimilar. Immunotherapy. PMID 31556762 DOI: 10.2217/imt-2019-0125 |
0.126 |
|
| 2017 |
Thomas M, Snead D, Mitchell D. An investigation into the potential role of brain angiogenesis inhibitor protein 3 (BAI3) in the tumorigenesis of small-cell carcinoma: a review of the surrounding literature. Journal of Receptor and Signal Transduction Research. 1-10. PMID 28537194 DOI: 10.1080/10799893.2017.1328441 |
0.126 |
|
| 2020 |
von Eiff D, Bozorgmehr F, Chung I, Bernhardt D, Rieken S, Liersch S, Muley T, Kobinger S, Thomas M, Christopoulos P, Steins M. Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients. Journal of Thoracic Disease. 12: 782-793. PMID 32274145 DOI: 10.21037/jtd.2019.12.74 |
0.125 |
|
| 2004 |
Schumacher A, Riesenbeck D, Braunheim M, Wewers D, Heinecke A, Semik M, Hoffknecht P, Macha HN, Klinke F, Schmidt EW, Willich N, Berdel WE, Thomas M. Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer (Amsterdam, Netherlands). 44: 89-97. PMID 15013587 DOI: 10.1016/j.lungcan.2003.10.004 |
0.125 |
|
| 2012 |
Gottschling S, Herpel E, Eberhardt WE, Heigener DF, Fischer JR, Köhne CH, Kortsik C, Kuhnt T, Muley T, Meister M, Bischoff HG, Klein P, Moldenhauer I, Schnabel PA, Thomas M, et al. The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP). Lung Cancer (Amsterdam, Netherlands). 77: 183-91. PMID 22483783 DOI: 10.1016/j.lungcan.2012.03.003 |
0.125 |
|
| 2013 |
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, Moro-Sibilot D, Camidge DR, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. The New England Journal of Medicine. 368: 2385-94. PMID 23724913 DOI: 10.1056/Nejmoa1214886 |
0.125 |
|
| 2018 |
Endris V, Buchhalter I, Allgäuer M, Rempel E, Lier A, Volckmar AL, Kirchner M, von Winterfeld M, Leichsenring J, Neumann O, Penzel R, Weichert W, Glimm H, Fröhling S, Winter H, ... ... Thomas M, et al. Measurement of Tumor Mutational Burden (TMB) in routine molecular diagnostics: in-silico and real-life analysis of three larger gene panels. International Journal of Cancer. PMID 30446996 DOI: 10.1002/ijc.32002 |
0.124 |
|
| 2016 |
Pérol M, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Kowalyszyn RD, Pikiel J, Lewanski CR, Thomas M, Dakhil S, Kim JH, Karaseva N, Yurasov S, et al. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer (Amsterdam, Netherlands). 93: 95-103. PMID 26898621 DOI: 10.1016/j.lungcan.2016.01.007 |
0.124 |
|
| 2020 |
Griesinger F, Eberhardt W, Nusch A, Reiser M, Zahn MO, Maintz C, Bernhardt C, Losem C, Stenzinger A, Heukamp LC, Büttner R, Marschner N, Jänicke M, Fleitz A, Spring L, ... ... Thomas M, et al. Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315). Lung Cancer (Amsterdam, Netherlands). PMID 33358484 DOI: 10.1016/j.lungcan.2020.10.012 |
0.123 |
|
| 2012 |
Brugger W, Thomas M. EGFR-TKI resistant non-small cell lung cancer (NSCLC): new developments and implications for future treatment. Lung Cancer (Amsterdam, Netherlands). 77: 2-8. PMID 22281074 DOI: 10.1016/j.lungcan.2011.12.014 |
0.123 |
|
| 2013 |
Huber RM, Reck M, Thomas M. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer. The European Respiratory Journal. 42: 1119-33. PMID 23429914 DOI: 10.1183/09031936.00143112 |
0.123 |
|
| 2018 |
Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, Shafie RAE, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy. Cancer Management and Research. 10: 6563-6569. PMID 30555261 DOI: 10.2147/CMAR.S180990 |
0.123 |
|
| 2023 |
Fink CA, Weykamp F, Adeberg S, Bozorgmehr F, Christopoulos P, Lang K, König L, Hörner-Rieber J, Thomas M, Steins M, El-Shafie RA, Rieken S, Bernhardt D, Debus J. Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy. Clinical and Translational Radiation Oncology. 42: 100665. PMID 37564923 DOI: 10.1016/j.ctro.2023.100665 |
0.123 |
|
| 2011 |
Natale RB, Thongprasert S, Greco FA, Thomas M, Tsai CM, Sunpaweravong P, Ferry D, Mulatero C, Whorf R, Thompson J, Barlesi F, Langmuir P, Gogov S, Rowbottom JA, Goss GD. Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1059-66. PMID 21282542 DOI: 10.1200/JCO.2010.28.5981 |
0.123 |
|
| 2021 |
Sebastian M, Eberhardt WEE, Hoffknecht P, Metzenmacher M, Wehler T, Kokowski K, Alt J, Schütte W, Büttner R, Heukamp LC, Stenzinger A, Jänicke M, Fleitz A, Zacharias S, Dille S, ... ... Thomas M, et al. KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315). Lung Cancer (Amsterdam, Netherlands). 154: 51-61. PMID 33611226 DOI: 10.1016/j.lungcan.2021.02.005 |
0.122 |
|
| 2020 |
Rheinheimer S, Heussel CP, Mayer P, Gaissmaier L, Bozorgmehr F, Winter H, Herth FJ, Muley T, Liersch S, Bischoff H, Kriegsmann M, El Shafie RA, Stenzinger A, Thomas M, Kauczor HU, et al. Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors. Cancers. 12. PMID 32340408 DOI: 10.3390/cancers12041046 |
0.122 |
|
| 2018 |
Weber R, Meister M, Muley T, Thomas M, Sültmann H, Warth A, Winter H, Herth FJF, Schneider MA. Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancer. International Journal of Oncology. PMID 30535430 DOI: 10.3892/ijo.2018.4654 |
0.122 |
|
| 2021 |
Bozorgmehr F, Kazdal D, Chung I, Kirchner M, Magios N, Kriegsmann M, Allgäuer M, Klotz LV, Muley T, El Shafie RA, Fischer JR, Faehling M, Stenzinger A, Thomas M, Christopoulos P. Versus Secondary Metastatic -Mutated Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11: 640048. PMID 33898315 DOI: 10.3389/fonc.2021.640048 |
0.122 |
|
| 2021 |
Christopoulos P, Bozorgmehr F, Brückner L, Chung I, Krisam J, Schneider MA, Stenzinger A, Eickhoff R, Mueller DW, Thomas M. Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial. Bmc Cancer. 21: 743. PMID 34182952 DOI: 10.1186/s12885-021-08460-w |
0.122 |
|
| 2016 |
Wiskemann J, Hummler S, Diepold C, Keil M, Abel U, Steindorf K, Beckhove P, Ulrich CM, Steins M, Thomas M. POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment. Bmc Cancer. 16: 499. PMID 27430336 DOI: 10.1186/s12885-016-2561-1 |
0.122 |
|
| 2016 |
Reck M, Thomas M, Kropf-Sanchen C, Mezger J, Socinski MA, Depenbrock H, Soldatenkova V, Brown J, Krause T, Thatcher N. Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE). Oncology Research and Treatment. 39: 539-547. PMID 27614872 DOI: 10.1159/000448085 |
0.122 |
|
| 2023 |
Garon EB, Lu S, Goto Y, De Marchi P, Paz-Ares L, Spigel DR, Thomas M, Yang JC, Ardizzoni A, Barlesi F, Orlov S, Yoshioka H, Mountzios G, Khanna S, Bossen C, et al. Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300910. PMID 37788412 DOI: 10.1200/JCO.23.00910 |
0.122 |
|
| 2020 |
Datta RR, Schönhage S, Dratsch T, Toader J, Müller DT, Wahba R, Kleinert R, Thomas M, Dieplinger G, Stippel DL, Bruns CJ, Fuchs HF. Learning curve of surgical novices using the single-port platform SymphonX: minimizing OR trauma to only one 15-mm incision. Surgical Endoscopy. PMID 32968918 DOI: 10.1007/s00464-020-07998-3 |
0.121 |
|
| 2015 |
Rieber J, Schmitt J, Warth A, Muley T, Kappes J, Eichhorn F, Hoffmann H, Heussel CP, Welzel T, Debus J, Thomas M, Steins M, Rieken S. Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas. European Journal of Medical Research. 20: 64. PMID 26272455 DOI: 10.1186/s40001-015-0158-9 |
0.121 |
|
| 2015 |
Thomas M, Fischer J, Andreas S, Kortsik C, Grah C, Serke M, von Eiff M, Witt C, Kollmeier J, Müller E, Schenk M, Schröder M, Villalobos M, Reinmuth N, Penzel R, et al. Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer. The European Respiratory Journal. 46: 219-29. PMID 25792638 DOI: 10.1183/09031936.00229014 |
0.121 |
|
| 2021 |
Elsayed M, Bozorgmehr F, Kazdal D, Volckmar AL, Sültmann H, Fischer JR, Kriegsmann M, Stenzinger A, Thomas M, Christopoulos P. Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11: 670483. PMID 33959513 DOI: 10.3389/fonc.2021.670483 |
0.12 |
|
| 2020 |
Kriegsmann M, Haag C, Weis CA, Steinbuss G, Warth A, Zgorzelski C, Muley T, Winter H, Eichhorn ME, Eichhorn F, Kriegsmann J, Christopolous P, Thomas M, Witzens-Harig M, Sinn P, et al. Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer. Cancers. 12. PMID 32560475 DOI: 10.3390/cancers12061604 |
0.12 |
|
| 2017 |
Bernhardt D, Adeberg S, Bozorgmehr F, Opfermann N, Hörner-Rieber J, König L, Kappes J, Thomas M, Unterberg A, Herth F, Heußel CP, Warth A, Debus J, Steins M, Rieken S. Outcome and prognostic factors in single brain metastases from small-cell lung cancer. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 29085978 DOI: 10.1007/s00066-017-1228-4 |
0.12 |
|
| 2016 |
Sparla A, Flach-Vorgang S, Villalobos M, Krug K, Kamradt M, Coulibaly K, Szecsenyi J, Thomas M, Gusset-Bährer S, Ose D. Individual difficulties and resources - a qualitative analysis in patients with advanced lung cancer and their relatives. Patient Preference and Adherence. 10: 2021-2029. PMID 27757022 DOI: 10.2147/PPA.S110667 |
0.12 |
|
| 2014 |
Askoxylakis V, Tanner J, Kappes J, Hoffmann H, Nicolay NH, Rief H, Debus J, Thomas M, Bischof M. Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis. Bmc Cancer. 14: 572. PMID 25104240 DOI: 10.1186/1471-2407-14-572 |
0.12 |
|
| 2008 |
Gatzemeier U, Griesinger F, Huber RM, Thomas M. [Foreword]. Onkologie. V. PMID 18545001 DOI: 10.1159/000128573 |
0.12 |
|
| 1999 |
Madden MC, Thomas MJ, Ghio AJ. Acetaldehyde (CH3CHO) production in rodent lung after exposure to metal-rich particles. Free Radical Biology & Medicine. 26: 1569-77. PMID 10401623 DOI: 10.1016/S0891-5849(99)00027-1 |
0.12 |
|
| 2007 |
Kreuter M, Vansteenkiste J, Griesinger F, Hoffmann H, Dienemann H, De Leyn P, Thomas M. Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol. Bmc Cancer. 7: 77. PMID 17488518 DOI: 10.1186/1471-2407-7-77 |
0.12 |
|
| 2018 |
Villalobos M, Czapiewski P, Reinmuth N, Fischer JR, Andreas S, Kortsik C, Serke M, Wolf M, Neuser P, Reuss A, Schnabel PA, Thomas M. ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer. Medical Oncology (Northwood, London, England). 35: 106. PMID 29905882 DOI: 10.1007/s12032-018-1169-5 |
0.12 |
|
| 2021 |
Griesinger F, Eberhardt W, Nusch A, Reiser M, Zahn MO, Maintz C, Bernhardt C, Losem C, Stenzinger A, Heukamp LC, Büttner R, Marschner N, Jänicke M, Fleitz A, Spring L, ... ... Thomas M, et al. Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184]. Lung Cancer (Amsterdam, Netherlands). PMID 34049721 DOI: 10.1016/j.lungcan.2021.05.005 |
0.12 |
|
| 2021 |
Gainor JF, Curigliano G, Kim DW, Lee DH, Besse B, Baik CS, Doebele RC, Cassier PA, Lopes G, Tan DSW, Garralda E, Paz-Ares LG, Cho BC, Gadgeel SM, Thomas M, et al. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study. The Lancet. Oncology. PMID 34118197 DOI: 10.1016/S1470-2045(21)00247-3 |
0.119 |
|
| 2010 |
Debus J, Eberhardt W, Hoffmann H, Passlick B, Rübe C, Thomas M. [The boundaries of curation]. Onkologie. 33: 12-20. PMID 20523102 DOI: 10.1159/000313972 |
0.119 |
|
| 2024 |
Besse B, Pons-Tostivint E, Park K, Hartl S, Forde PM, Hochmair MJ, Awad MM, Thomas M, Goss G, Wheatley-Price P, Shepherd FA, Florescu M, Cheema P, Chu QSC, Kim SW, et al. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial. Nature Medicine. PMID 38351187 DOI: 10.1038/s41591-024-02808-y |
0.119 |
|
| 2016 |
Bernhardt D, Bozorgmehr F, Adeberg S, Opfermann N, von Eiff D, Rieber J, Kappes J, Foerster R, König L, Thomas M, Debus J, Steins M, Rieken S. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation. Lung Cancer (Amsterdam, Netherlands). 101: 76-81. PMID 27794411 DOI: 10.1016/j.lungcan.2016.09.010 |
0.119 |
|
| 2020 |
Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial. Bmc Cancer. 20: 806. PMID 32842974 DOI: 10.1186/s12885-020-07264-8 |
0.119 |
|
| 2021 |
Daniello L, Elshiaty M, Bozorgmehr F, Kuon J, Kazdal D, Schindler H, Shah R, Volckmar AL, Lusky F, Diekmann L, Liersch S, Faehling M, Muley T, Kriegsmann M, Benesova K, ... ... Thomas M, et al. Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11: 703893. PMID 34268127 DOI: 10.3389/fonc.2021.703893 |
0.119 |
|
| 2020 |
Dietz S, Christopoulos P, Yuan Z, Angeles AK, Gu L, Volckmar AL, Ogrodnik SJ, Janke F, Fratte CD, Zemojtel T, Schneider MA, Kazdal D, Endris V, Meister M, Muley T, ... ... Thomas M, et al. Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. Ebiomedicine. 62: 103103. PMID 33161228 DOI: 10.1016/j.ebiom.2020.103103 |
0.119 |
|
| 2016 |
Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, et al. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC). Lung Cancer (Amsterdam, Netherlands). 91: 41-7. PMID 26711933 DOI: 10.1016/j.lungcan.2015.11.014 |
0.119 |
|
| 2003 |
Reinmuth N, Brandt B, Semik M, Kunze WP, Achatzy R, Scheld HH, Broermann P, Berdel WE, Macha HN, Thomas M. Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 36: 265-70. PMID 12009236 DOI: 10.1016/s0169-5002(02)00009-0 |
0.118 |
|
| 2008 |
Thomas M, Rübe C, Hoffknecht P, Macha HN, Freitag L, Linder A, Willich N, Hamm M, Sybrecht GW, Ukena D, Deppermann KM, Dröge C, Riesenbeck D, Heinecke A, Sauerland C, et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. The Lancet. Oncology. 9: 636-48. PMID 18583190 DOI: 10.1016/S1470-2045(08)70156-6 |
0.118 |
|
| 2023 |
Muley T, Schneider MA, Meister M, Thomas M, Heußel CP, Kriegsmann M, Holdenrieder S, Wehnl B, Rolny V, Mang A, Gerber R, Herth F. CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 37840516 DOI: 10.3233/TUB-220042 |
0.118 |
|
| 2023 |
Longuespée R, Kunz J, Fresnais M, Foerster KI, Burhenne J, Thomas M, Kazdal D, Stenzinger A, Christopoulos P, Haefeli WE. Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: a case report. British Journal of Clinical Pharmacology. PMID 37815301 DOI: 10.1111/bcp.15924 |
0.118 |
|
| 2004 |
Semik M, Riesenbeck D, Linder A, Schmid C, Hoffknecht P, Heinecke A, Scheld H, Thomas M. Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 26: 1205-1210. PMID 15678591 |
0.118 |
|
| 2016 |
Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Thomas M, Schuler M, Liu G, et al. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. The Lancet. Oncology. PMID 26973324 DOI: 10.1016/S1470-2045(15)00614-2 |
0.118 |
|
| 2016 |
Hearing MC, Jedynak J, Ebner SR, Ingebretson A, Asp AJ, Fischer RA, Schmidt C, Larson EB, Thomas MJ. Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement. Proceedings of the National Academy of Sciences of the United States of America. PMID 26739562 DOI: 10.1073/Pnas.1519248113 |
0.118 |
|
| 2018 |
Bernhardt D, Hommertgen A, Schmitt D, El Shafie R, Paul A, König L, Mair-Walther J, Krisam J, Klose C, Welzel T, Hörner-Rieber J, Kappes J, Thomas M, Heußel CP, Steins M, et al. Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial. Trials. 19: 388. PMID 30012190 DOI: 10.1186/s13063-018-2745-x |
0.118 |
|
| 2011 |
Jensen AD, Münter MW, Bischoff HG, Haselmann R, Haberkorn U, Huber PE, Thomas M, Debus J, Herfarth KK. Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial. Cancer. 117: 2986-94. PMID 21264838 DOI: 10.1002/cncr.25888 |
0.118 |
|
| 2019 |
Volckmar AL, Leichsenring J, Kirchner M, Christopoulos P, Neumann O, Budczies J, de Oliveira CMM, Rempel E, Buchhalter I, Brandt R, Allgäuer M, Talla SB, von Winterfeld M, Herpel E, Goeppert B, ... ... Thomas M, et al. Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases. International Journal of Cancer. PMID 30653256 DOI: 10.1002/ijc.32133 |
0.117 |
|
| 2021 |
Volckmar AL, Christopoulos P, Kirchner M, Allgäuer M, Neumann O, Budczies J, Rempel E, Horak P, Glade J, Goldschmid H, Seker-Cin H, Brandt R, Kriegsmann M, Leichsenring J, Winter H, ... ... Thomas M, et al. Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung Cancer (Amsterdam, Netherlands). 154: 131-141. PMID 33667718 DOI: 10.1016/j.lungcan.2021.02.022 |
0.117 |
|
| 2004 |
Müller-Tidow C, Diederichs S, Thomas M, Serve H. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). S145-50. PMID 15552795 DOI: 10.1016/j.lungcan.2004.07.979 |
0.117 |
|
| 2021 |
Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel CP, Herth FJ, Winter H, Meister M, Muley T, Fröhling S, Peters S, Seliger B, ... ... Thomas M, et al. A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma. Oncoimmunology. 10: 1860586. PMID 33520406 DOI: 10.1080/2162402X.2020.1860586 |
0.117 |
|
| 2014 |
Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, ... ... Thomas M, et al. The European initiative for quality management in lung cancer care. The European Respiratory Journal. 43: 1254-77. PMID 24659546 DOI: 10.1183/09031936.00106913 |
0.117 |
|
| 2013 |
Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, et al. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2895-902. PMID 23835707 DOI: 10.1200/JCO.2012.47.1102 |
0.117 |
|
| 2010 |
Schiller JH, von Pawel J, Schütt P, Ansari RH, Thomas M, Saleh M, McCroskey RD, Pfeifer W, Marsland TA, Kloecker GH, Sebastian M, Pirker R, Kurek R, Beadman C, Socinski MA. Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1977-85. PMID 20978446 DOI: 10.1097/JTO.0b013e3181f4a5c9 |
0.115 |
|
| 2022 |
Ball M, Christopoulos P, Kirchner M, Allgaeuer M, Brandt R, Winter H, Heussel CP, Herth F, Froehling S, Savai R, Kriegsmann M, Schirmacher P, Peters S, Thomas M, Stenzinger A, et al. Histological and Molecular Plasticity of ALK-positive Non-Small-Cell Lung Cancer under Targeted Therapy - a Case Report. Cold Spring Harbor Molecular Case Studies. PMID 35058282 DOI: 10.1101/mcs.a006156 |
0.115 |
|
| 2021 |
Angeles AK, Christopoulos P, Yuan Z, Bauer S, Janke F, Ogrodnik SJ, Reck M, Schlesner M, Meister M, Schneider MA, Dietz S, Stenzinger A, Thomas M, Sültmann H. Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis. Npj Precision Oncology. 5: 100. PMID 34876698 DOI: 10.1038/s41698-021-00239-3 |
0.115 |
|
| 2022 |
Schneider MA, Rozy A, Wrenger S, Christopoulos P, Muley T, Thomas M, Meister M, Welte T, Chorostowska-Wynimko J, Janciauskiene S. Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study. Frontiers in Oncology. 12: 772076. PMID 35174082 DOI: 10.3389/fonc.2022.772076 |
0.115 |
|
| 2023 |
Christopoulos P, Prawitz T, Hong JL, Lin HM, Hernandez L, Jin S, Tan M, Proskorovsky I, Lin J, Zhang P, Patel JD, Ou SI, Thomas M, Stenzinger A. Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. Lung Cancer (Amsterdam, Netherlands). 179: 107191. PMID 37058788 DOI: 10.1016/j.lungcan.2023.107191 |
0.115 |
|
| 2020 |
Bossert J, Forstner J, Villalobos M, Siegle A, Jung C, Deis N, Thomas M, Wensing M, Krug K. What patients with lung cancer with comorbidity tell us about interprofessional collaborative care across healthcare sectors: qualitative interview study. Bmj Open. 10: e036495. PMID 32753449 DOI: 10.1136/bmjopen-2019-036495 |
0.115 |
|
| 2014 |
Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Thomas M, Schuler M, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. The New England Journal of Medicine. 370: 1189-97. PMID 24670165 DOI: 10.1056/NEJMoa1311107 |
0.114 |
|
| 2015 |
Schneider MA, Granzow M, Warth A, Schnabel PA, Thomas M, Herth FJ, Dienemann H, Muley T, Meister M. Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25901080 DOI: 10.1158/1078-0432.CCR-14-2464 |
0.114 |
|
| 2023 |
Schütte W, Gütz S, Nehls W, Blum TG, Brückl W, Buttmann-Schweiger N, Büttner R, Christopoulos P, Delis S, Deppermann KM, Dickgreber N, Eberhardt W, Eggeling S, Fleckenstein J, Flentje M, ... ... Thomas M, et al. [Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]. Pneumologie (Stuttgart, Germany). 77: 671-813. PMID 37884003 DOI: 10.1055/a-2029-0134 |
0.114 |
|
| 2022 |
Blasi M, Eichhorn ME, Christopoulos P, Winter H, Heußel CP, Herth FJ, El Shafie R, Kriegsmann K, Kriegsmann M, Stenzinger A, Bischoff H, Thomas M, Kuon J. Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis. Bmc Pulmonary Medicine. 22: 255. PMID 35761214 DOI: 10.1186/s12890-022-02043-6 |
0.114 |
|
| 2018 |
Christopoulos P, Schneider MA, Bozorgmehr F, Kuon J, Engel-Riedel W, Kollmeier J, Baum V, Muley T, Schnabel PA, Bischoff H, Grohé C, Serke M, Thomas M, Fisch P, Meister M. Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance. Lung Cancer (Amsterdam, Netherlands). 119: 48-55. PMID 29656752 DOI: 10.1016/j.lungcan.2018.03.002 |
0.114 |
|
| 2021 |
Blasi M, Kazdal D, Thomas M, Christopoulos P, Kriegsmann M, Brandt R, Volckmar AL, Kirchner M, Heußel CP, Stenzinger A, Kuon J. Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report. Case Reports in Oncology. 14: 477-482. PMID 33976623 DOI: 10.1159/000513904 |
0.114 |
|
| 2020 |
Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, ... ... Thomas M, et al. Capmatinib in Exon 14-Mutated or -Amplified Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 383: 944-957. PMID 32877583 DOI: 10.1056/NEJMoa2002787 |
0.114 |
|
| 2017 |
Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S, Koecher K, Karl JP, Thomas M, Dolnikowski G, Li L, et al. Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults. The American Journal of Clinical Nutrition. PMID 28179226 DOI: 10.3945/Ajcn.116.146928 |
0.113 |
|
| 2016 |
Marien E, Meister M, Muley T, Gomez Del Pulgar T, Derua R, Spraggins JM, Van de Plas R, Vanderhoydonc F, Machiels J, Binda MM, Dehairs J, Willette Brown J, Hu Y, Dienemann H, Thomas M, et al. Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma. Oncotarget. PMID 26862848 DOI: 10.18632/Oncotarget.7179 |
0.113 |
|
| 2024 |
Blasi M, Kuon J, Lüders H, Misch D, Kauffmann-Guerrero D, Hilbrandt M, Kazdal D, Falkenstern-Ge RF, Hackanson B, Dintner S, Faehling M, Kirchner M, Volckmar AL, Kopp HG, Allgäuer M, ... ... Thomas M, et al. First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations. European Journal of Cancer (Oxford, England : 1990). 199: 113556. PMID 38271745 DOI: 10.1016/j.ejca.2024.113556 |
0.113 |
|
| 2020 |
Kriegsmann M, Zgorzelski C, Casadonte R, Schwamborn K, Muley T, Winter H, Eichhorn M, Eichhorn F, Warth A, Deininger SO, Christopoulos P, Thomas M, Longerich T, Stenzinger A, Weichert W, et al. Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes. Cancers. 12. PMID 32967325 DOI: 10.3390/cancers12092704 |
0.113 |
|
| 2023 |
Frost N, Bleckmann A, Griesinger F, Grohé C, Janning M, Kollmeier J, Reinmuth N, Sebastian M, Thomas M, Reck M. Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122). Clinical Lung Cancer. PMID 37169628 DOI: 10.1016/j.cllc.2023.04.009 |
0.113 |
|
| 2020 |
Krug K, Bossert J, Stooß L, Siegle A, Villalobos M, Hagelskamp L, Jung C, Thomas M, Wensing M. Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32880008 DOI: 10.1007/s00520-020-05724-2 |
0.112 |
|
| 2021 |
Goldmann T, Schmitt B, Müller J, Kröger M, Scheufele S, Marwitz S, Nitschkowski D, Schneider MA, Meister M, Muley T, Thomas M, Kugler C, Rabe KF, Siebert R, Reck M, et al. DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer. Clinical Epigenetics. 13: 38. PMID 33596996 DOI: 10.1186/s13148-021-01024-6 |
0.112 |
|
| 2021 |
Cho BC, Felip E, Hayashi H, Thomas M, Lu S, Besse B, Sun T, Martinez M, Sethi SN, Shreeve SM, Spira AI. MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small cell lung cancer. Future Oncology (London, England). PMID 34911336 DOI: 10.2217/fon-2021-0923 |
0.112 |
|
| 2023 |
Seker-Cin H, Tay TKY, Kazdal D, Kluck K, Ball M, Neumann O, Winter H, Herth F, Heußel CP, Savai R, Schirmacher P, Thomas M, Budczies J, Allgäuer M, Christopoulos P, et al. Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications. Lung Cancer (Amsterdam, Netherlands). 184: 107317. PMID 37586177 DOI: 10.1016/j.lungcan.2023.107317 |
0.112 |
|
| 2019 |
Thatcher N, Goldschmidt JH, Thomas M, Schenker M, Pan Z, Paz-Ares L, Breder V, Ostoros G, Hanes V. Efficacy & Safety of Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Non-small Cell Lung Cancer(MAPLE):A Randomized,Double-blind,Phase 3 Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30617139 DOI: 10.1158/1078-0432.CCR-18-2702 |
0.112 |
|
| 2024 |
Sebastian M, Eberhardt WEE, von der Heyde E, Dörfel S, Wiegand J, Schiefer C, Losem C, Jänicke M, Fleitz A, Zacharias S, Kaiser-Osterhues A, Hipper A, Dietel C, Bleckmann A, Benkelmann R, ... ... Thomas M, et al. Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315). International Journal of Cancer. PMID 38329180 DOI: 10.1002/ijc.34868 |
0.112 |
|
| 2010 |
Steins MB, Reinmuth N, Bischoff H, Kindermann M, Thomas M. Targeting the epidermal growth factor receptor in non-small cell lung cancer. Onkologie. 33: 704-9. PMID 21124044 DOI: 10.1159/000322214 |
0.112 |
|
| 2023 |
Blasi M, Kuon J, Shah R, Bozorgmehr F, Eichhorn F, Liersch S, Stenzinger A, Heußel CP, Herth FJ, Thomas M, Christopoulos P. Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study. Clinical Lung Cancer. PMID 37391339 DOI: 10.1016/j.cllc.2023.06.010 |
0.112 |
|
| 2012 |
Campa D, Müller P, Edler L, Knoefel L, Barale R, Heussel CP, Thomas M, Canzian F, Risch A. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis. International Journal of Cancer. 131: 2920-8. PMID 22473764 DOI: 10.1002/Ijc.27567 |
0.111 |
|
| 2012 |
Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, et al. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. The Lancet. Oncology. 13: 247-55. PMID 22341744 DOI: 10.1016/S1470-2045(12)70063-3 |
0.111 |
|
| 2016 |
Reck M, Luft A, Szczesna A, Havel L, Kim SW, Akerley W, Pietanza MC, Wu YL, Zielinski C, Thomas M, Felip E, Gold K, Horn L, Aerts J, Nakagawa K, et al. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27458307 DOI: 10.1200/JCO.2016.67.6601 |
0.111 |
|
| 2021 |
Boch T, Frost N, Sommer L, Overbeck TR, Michaeli CT, Szuszies CJ, Rieckmann LM, Beumer N, Imbusch CD, Winter H, Thomas M, Roeper J, Janning M, Griesinger F, Wermke M, et al. Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery. Lung Cancer (Amsterdam, Netherlands). 164: 46-51. PMID 34998106 DOI: 10.1016/j.lungcan.2021.11.009 |
0.111 |
|
| 2016 |
Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt WE, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, ... ... Thomas M, et al. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: 85-93. PMID 26762743 DOI: 10.1016/j.jtho.2015.09.014 |
0.111 |
|
| 2011 |
Knoefel LF, Werle-Schneider G, Dally H, Müller PJ, Edler L, Bartsch H, Tuengerthal S, Heussel CP, Reinmuth N, Thomas M, Risch A. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 183-9. PMID 21107291 DOI: 10.1097/Jto.0B013E3181F8A20E |
0.11 |
|
| 2021 |
Kazdal D, Rempel E, Oliveira C, Allgäuer M, Harms A, Singer K, Kohlwes E, Ormanns S, Fink L, Kriegsmann J, Leichsenring M, Kriegsmann K, Stögbauer F, Tavernar L, Leichsenring J, ... ... Thomas M, et al. Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma. Translational Lung Cancer Research. 10: 1666-1678. PMID 34012783 DOI: 10.21037/tlcr-20-1168 |
0.11 |
|
| 2019 |
Thatcher N, Goldschmidt JH, Thomas M, Schenker M, Pan Z, Rodriguez LP, Breder V, Ostoros G, Hanes V. Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 3193. PMID 31092617 DOI: 10.1158/1078-0432.CCR-19-1098 |
0.11 |
|
| 2018 |
Schneider MA, Muley T, Weber R, Wessels S, Thomas M, Herth FJF, Kahn NC, Eberhardt R, Winter H, Heussel G, Warth A, Herold-Mende C, Meister M. Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC. Cancers. 10. PMID 30518088 DOI: 10.3390/cancers10120486 |
0.11 |
|
| 2010 |
Scagliotti G, Novello S, von Pawel J, Reck M, Pereira JR, Thomas M, Abrão Miziara JE, Balint B, De Marinis F, Keller A, Arén O, Csollak M, Albert I, Barrios CH, Grossi F, et al. Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1835-42. PMID 20212250 DOI: 10.1200/Jco.2009.26.1321 |
0.109 |
|
| 2014 |
Muley TR, Sianidou M, Thomas M, Bischoff H, Dienemann H, Meister M, Schneider MA, Schnabel PA, Warth A. Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer. Anticancer Research. 34: 3707-13. PMID 24982391 |
0.109 |
|
| 2017 |
Bernhardt D, König L, Aufderstrasse S, Krisam J, Hoerner-Rieber J, Adeberg S, Bozorgmehr F, El Shafie R, Lang K, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Marcrom S, et al. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices. Clinical Lung Cancer. PMID 29373273 DOI: 10.1016/j.cllc.2017.12.004 |
0.109 |
|
| 2021 |
Christopoulos P, Dietz S, Angeles AK, Rheinheimer S, Kazdal D, Volckmar AL, Janke F, Endris V, Meister M, Kriegsmann M, Zemojtel T, Reck M, Stenzinger A, Thomas M, Sültmann H. Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies. Translational Lung Cancer Research. 10: 2118-2131. PMID 34164264 DOI: 10.21037/tlcr-21-32 |
0.109 |
|
| 2020 |
Catarata MJ, Medeiros R, Oliveira MJ, Pêgo A, Frade JG, Martins MF, Robalo Cordeiro C, Herth FJF, Thomas M, Kriegsmann M, Meister M, Schneider MA, Muley T, Ribeiro R. Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies. Cancers. 12. PMID 33353148 DOI: 10.3390/cancers12123834 |
0.109 |
|
| 2015 |
Kuehr L, Wiskemann J, Abel U, Ulrich CM, Hummler S, Thomas M. Exercise in patients with non-small cell lung cancer. Medicine and Science in Sports and Exercise. 46: 656-63. PMID 24042307 DOI: 10.1249/MSS.0000000000000158 |
0.109 |
|
| 2014 |
Reinmuth N, Kloos S, Warth A, Risch A, Muley T, Hoffmann H, Thomas M, Meister M. Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer. Human Pathology. 45: 1162-8. PMID 24745618 DOI: 10.1016/J.Humpath.2014.01.010 |
0.109 |
|
| 2014 |
Hummler S, Thomas M, Hoffmann B, Gärtner P, Zoz M, Huber G, Ulrich CM, Wiskemann J. Physical performance and psychosocial status in lung cancer patients: results from a pilot study. Oncology Research and Treatment. 37: 36-41. PMID 24613907 DOI: 10.1159/000358157 |
0.109 |
|
| 2020 |
Shah R, Klotz LV, Chung I, Feißt M, Schneider MA, Riedel J, Bischoff H, Eichhorn ME, Thomas M. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol. Clinical Lung Cancer. PMID 33158765 DOI: 10.1016/j.cllc.2020.10.005 |
0.109 |
|
| 2014 |
Eberhardt WE, Mitchell P, Schiller JH, Brown MP, Thomas M, Mills G, Jehl V, Urva SR, De Leo JJ, Gogov S, Papadimitrakopoulou V. Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer. Investigational New Drugs. 32: 123-34. PMID 23579358 DOI: 10.1007/s10637-013-9958-3 |
0.109 |
|
| 2014 |
Kreuter M, Vansteenkiste J, Herth FJ, Fischer JR, Eberhardt W, Zuna I, Reinmuth N, Griesinger F, Thomas M. Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer. Respiration; International Review of Thoracic Diseases. 87: 204-10. PMID 24192055 DOI: 10.1159/000355361 |
0.108 |
|
| 2021 |
Brunn D, Turkowski K, Günther S, Weigert A, Muley T, Kriegsmann M, Winter H, Dammann RH, Stathopoulos GT, Thomas M, Guenther A, Grimminger F, Pullamsetti SS, Seeger W, Savai R. Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. Cancers. 13. PMID 33430083 DOI: 10.3390/cancers13020208 |
0.108 |
|
| 2017 |
Bernhardt D, Adeberg S, Bozorgmehr F, Opfermann N, Hoerner-Rieber J, König L, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Debus J, Steins M, Rieken S. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy. Journal of Neuro-Oncology. PMID 28560661 DOI: 10.1007/s11060-017-2510-0 |
0.107 |
|
| 2014 |
Stuart CH, Horita DA, Thomas MJ, Salsbury FR, Lively MO, Gmeiner WH. Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells. Bioconjugate Chemistry. 25: 406-13. PMID 24450459 DOI: 10.1021/bc4005427 |
0.107 |
|
| 2011 |
Rothwell PE, Kourrich S, Thomas MJ. Synaptic adaptations in the nucleus accumbens caused by experiences linked to relapse. Biological Psychiatry. 69: 1124-6. PMID 21329910 DOI: 10.1016/j.biopsych.2010.12.028 |
0.107 |
|
| 2005 |
Müller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwäble J, Plewka S, Thomas M, Metzger R, Schneider PM, Brandts CH, Berdel WE, Serve H. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Research. 65: 1778-82. PMID 15753374 DOI: 10.1158/0008-5472.CAN-04-3388 |
0.107 |
|
| 2013 |
Thomas MJ, Schultz TJ, Hannaford N, Runciman WB. Failures in transition: learning from incidents relating to clinical handover in acute care. Journal For Healthcare Quality : Official Publication of the National Association For Healthcare Quality. 35: 49-56. PMID 22268639 DOI: 10.1111/j.1945-1474.2011.00189.x |
0.106 |
|
| 2004 |
Cullen M, Szczepura A, Thomas M, Kielhorn A. Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice. Lung Cancer (Amsterdam, Netherlands). 43: 113-5. PMID 14698545 DOI: 10.1016/j.lungcan.2003.07.008 |
0.106 |
|
| 2019 |
Christopoulos P, Budczies J, Kirchner M, Dietz S, Sültmann H, Thomas M, Stenzinger A. Defining molecular risk in ALK NSCLC. Oncotarget. 10: 3093-3103. PMID 31139322 DOI: 10.18632/oncotarget.26886 |
0.106 |
|
| 2006 |
Reinmuth N, Piegelbrock E, Raedel M, Fehrmann N, Hintelmann H, Wagner R, Berdel WE, Thomas M, Freitag L, Mesters RM. Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 55: 53-60. PMID 17067717 DOI: 10.1016/j.lungcan.2006.09.025 |
0.106 |
|
| 2014 |
Garon EB, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Gorbunova V, Kowalyszyn RD, Pikiel J, Czyzewicz G, Orlov SV, Lewanski CR, Thomas M, Bidoli P, et al. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. Lancet (London, England). 384: 665-73. PMID 24933332 DOI: 10.1016/S0140-6736(14)60845-X |
0.105 |
|
| 2002 |
Thomas M, Karmiloff-Smith A. Are developmental disorders like cases of adult brain damage? Implications from connectionist modelling. The Behavioral and Brain Sciences. 25: 727-50; discussion 7. PMID 14598624 DOI: 10.1017/S0140525X02000134 |
0.105 |
|
| 2020 |
Kuon J, Hommertgen A, Krisam J, Lasitschka F, Stenzinger A, Blasi M, Bozorgmehr F, Maenz M, Kieser M, Schneider M, Thomas M. Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial. Trials. 21: 352. PMID 32321565 DOI: 10.1186/s13063-020-04280-8 |
0.105 |
|
| 2015 |
Schuette W, Schirmacher P, Eberhardt WE, Fischer JR, von der Schulenburg JG, Mezger J, Schumann C, Serke M, Zaun S, Dietel M, Thomas M. EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non-Small Cell Lung Cancer in Germany: An Observational Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26070531 DOI: 10.1158/1055-9965.EPI-14-1149 |
0.105 |
|
| 2021 |
Klotz LV, Gruenewald C, Bulut EL, Eichhorn F, Thomas M, Shah R, Kriegsmann M, Schmidt W, Kofler O, Winter H, Eichhorn ME. Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center Experience. Respiration; International Review of Thoracic Diseases. 1-9. PMID 34384085 DOI: 10.1159/000517334 |
0.105 |
|
| 2022 |
Wiedemann C, Kazdal D, Cvetkovic J, Kunz J, Fisch D, Kirchner M, Kriegsmann M, Sueltmann H, Heussel CP, Bischoff H, Thomas M, Stenzinger A, Christopoulos P. Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report. Cold Spring Harbor Molecular Case Studies. PMID 36207130 DOI: 10.1101/mcs.a006234 |
0.104 |
|
| 2019 |
Kuon J, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, Stahlhut K, Heider A, ... ... Thomas M, et al. Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment. Oncology Research and Treatment. 1-9. PMID 31634889 DOI: 10.1159/000502751 |
0.104 |
|
| 2016 |
Schneider MA, Muley T, Kahn NC, Warth A, Thomas M, Herth FJ, Dienemann H, Meister M. Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma. Oncotarget. PMID 27713145 DOI: 10.18632/oncotarget.12474 |
0.103 |
|
| 2021 |
Metzenmacher M, Kopp HG, Griesinger F, Reinmuth N, Sebastian M, Serke M, Waller CF, Thomas M, Eggert J, Schmid-Bindert G, Hoiczyk M, Christoph DC, Kimmich M, Deuß B, Seifert S, et al. A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer. Therapeutic Advances in Medical Oncology. 13: 1758835921996506. PMID 34104223 DOI: 10.1177/1758835921996506 |
0.103 |
|
| 2019 |
Eichhorn F, Klotz LV, Bischoff H, Thomas M, Lasitschka F, Winter H, Hoffmann H, Eichhorn ME. Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial. Bmc Cancer. 19: 413. PMID 31046714 DOI: 10.1186/s12885-019-5624-2 |
0.102 |
|
| 2022 |
Schindler H, Lusky F, Daniello L, Elshiaty M, Gaissmaier L, Benesova K, Souto-Carneiro M, Angeles AK, Janke F, Eichhorn F, Kazdal D, Schneider M, Liersch S, Klemm S, Schnitzler P, ... ... Thomas M, et al. Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors. Frontiers in Oncology. 12: 1010660. PMID 36387148 DOI: 10.3389/fonc.2022.1010660 |
0.102 |
|
| 2021 |
Villalobos M, Deis N, Wesselmann S, Seufferlein T, Ehlers F, Mahler C, Letsch A, Bausewein C, Krones T, Gaiser K, Engeser P, Kanzler M, Lauerer M, Siegle A, Unsöld L, ... ... Thomas M, et al. [Heidelberg Milestones Communication (HeiMeKOM) - Experiences, Best Practice Examples and Recommendations from the Final Symposium on January 30 and 31 in 2020]. Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany)). PMID 33862649 DOI: 10.1055/a-1375-0922 |
0.102 |
|
| 2021 |
Bossert J, Ludwig M, Wronski P, Koetsenruijter J, Krug K, Villalobos M, Jacob J, Walker J, Thomas M, Wensing M. Lung cancer patients' comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study. Npj Primary Care Respiratory Medicine. 31: 2. PMID 33510177 DOI: 10.1038/s41533-020-00214-8 |
0.102 |
|
| 2016 |
Volckmar AL, Endris V, Bozorgmehr F, Lier C, Porcel C, Kirchner M, Leichsenring J, Penzel R, Thomas M, Schirmacher P, Warth A, Stenzinger A. Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report. Diagnostic Pathology. 11: 133. PMID 27863497 DOI: 10.1186/s13000-016-0581-4 |
0.102 |
|
| 2022 |
Dong A, Pan X, Lin CW, Huang YW, Krause H, Pan P, Baim A, Thomas MJ, Chen X, Yu J, Michaelis L, Liu P, Wang LS, Atallah E. A Pilot Clinical Study to Investigate the Hypomethylating Properties of Freeze-dried Black Raspberries in Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasm. Journal of Cancer Prevention. 27: 129-138. PMID 35864858 DOI: 10.15430/JCP.2022.27.2.129 |
0.102 |
|
| 2021 |
Griesinger F, Thomas M. [When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer - Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?] Pneumologie (Stuttgart, Germany). 75: 641-643. PMID 34525486 DOI: 10.1055/a-1486-9057 |
0.102 |
|
| 2021 |
Griesinger F, Thomas M. [When to test in biomarker-stratified therapy of non-small cell lung cancer - Biomarker-stratified therapy of Non-small cell lung cancer: when and what to test?] Deutsche Medizinische Wochenschrift (1946). 146: 559-561. PMID 33853174 DOI: 10.1055/a-1383-5231 |
0.102 |
|
| 2021 |
Saalfeld FC, Wenzel C, Christopoulos P, Merkelbach-Bruse S, Reissig TM, Laßmann S, Thiel S, Stratmann JA, Marienfeld R, Berger J, Desuki A, Velthaus JL, Kauffmann-Guerrero D, Stenzinger A, Michels S, ... ... Thomas M, et al. Brief Report: Efficacy of immune checkpoint inhibitors alone or in combination with chemotherapy in NSCLC harboring ERBB2 mutations. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34245914 DOI: 10.1016/j.jtho.2021.06.025 |
0.101 |
|
| 2020 |
Regnery S, Eichkorn T, Weykamp F, Held T, Dinges LA, Schunn F, Winter H, Thomas M, Debus J, El Shafie RA, Adeberg S, Hörner-Rieber J. Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors. Cancers. 12. PMID 33027940 DOI: 10.3390/cancers12102862 |
0.101 |
|
| 2019 |
Villalobos M, Czapiewski P, Reinmuth N, Fischer JR, Andreas S, Kortsik C, Serke M, Wolf M, Neuser P, Reuss A, Schnabel PA, Thomas M. Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab. Oncology Letters. 17: 4891-4900. PMID 31186697 DOI: 10.3892/ol.2019.10153 |
0.101 |
|
| 2023 |
Eichkorn T, Lischalk JW, Stüwe C, Tonndorf-Martini E, Schubert K, Dinges LA, Regnery S, Bozorgmehr F, König L, Christopoulos P, Hörner-Rieber J, Adeberg S, Herfarth K, Winter H, Thomas M, et al. High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes. Frontiers in Oncology. 12: 1035370. PMID 36713565 DOI: 10.3389/fonc.2022.1035370 |
0.101 |
|
| 2014 |
Miller EA, Froehlich HE, Cocherell DE, Thomas MJ, Cech JJ, Klimley AP, Fangue NA. Effects of acoustic tagging on juvenile green sturgeon incision healing, swimming performance, and growth Environmental Biology of Fishes. 97: 647-658. DOI: 10.1007/S10641-013-0167-X |
0.101 |
|
| 2012 |
Herpel E, Schnabel PA, Steins M, Dienemann H, Herth FJ, Thomas M, Schirmacher P, Warth A. Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer. Histopathology. 61: 465-72. PMID 22463725 DOI: 10.1111/j.1365-2559.2012.04248.x |
0.101 |
|
| 2019 |
Bendell JC, Bischoff HG, Hwang J, Reinhardt HC, Zander T, Wang X, Hynes S, Pitou C, Campbell R, Iversen P, Farrington DL, Bell-McGuinn K, Thomas M. A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer. Investigational New Drugs. PMID 31707688 DOI: 10.1007/s10637-019-00873-6 |
0.101 |
|
| 2014 |
Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ, van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP, et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. Plos Pathogens. 10: e1004250. PMID 25144235 DOI: 10.1371/Journal.Ppat.1004250 |
0.1 |
|
| 2004 |
Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K, Zänker KS, Metzger R, Schneider PM, Gerke V, Thomas M, Berdel WE, Serve H, Müller-Tidow C. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Research. 64: 5564-9. PMID 15313892 DOI: 10.1158/0008-5472.CAN-04-2004 |
0.1 |
|
| 2018 |
Christopoulos P, Endris V, Bozorgmehr F, Elsayed M, Kirchner M, Ristau J, Buchhalter I, Penzel R, Herth FJ, Heussel CP, Eichhorn M, Muley T, Meister M, Fischer JR, Rieken S, ... ... Thomas M, et al. EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ NSCLC. International Journal of Cancer. PMID 29363116 DOI: 10.1002/ijc.31275 |
0.099 |
|
| 2022 |
Christopoulos P, Kluck K, Kirchner M, Lüders H, Roeper J, Falkenstern-Ge RF, Szewczyk M, Sticht F, Saalfeld FC, Wesseler C, Hackanson B, Dintner S, Faehling M, Kuon J, Janning M, ... ... Thomas M, et al. The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. European Journal of Cancer (Oxford, England : 1990). 170: 106-118. PMID 35598358 DOI: 10.1016/j.ejca.2022.04.020 |
0.099 |
|
| 2004 |
Thomas M, Hoffknecht P, Droege C, Baisch A, Reinmuth N, Kreuter M, Lange T, Berdel WE. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. Lung Cancer (Amsterdam, Netherlands). 45: S99-105. PMID 15552789 DOI: 10.1016/j.lungcan.2004.07.985 |
0.099 |
|
| 2022 |
Roeper J, Christopoulos P, Falk M, Heukamp LC, Tiemann M, Stenzinger A, Thomas M, Griesinger F. co-mutations as an independent prognostic factor in 2nd and further line therapy- mutated non-small cell lung cancer IV patients treated with osimertinib. Translational Lung Cancer Research. 11: 4-13. PMID 35242623 DOI: 10.21037/tlcr-21-754 |
0.099 |
|
| 2005 |
Junker K, Stachetzki U, Rademacher D, Linder A, Macha HN, Heinecke A, Müller KM, Thomas M. HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy. Lung Cancer (Amsterdam, Netherlands). 48: 59-67. PMID 15777971 DOI: 10.1016/j.lungcan.2004.10.010 |
0.099 |
|
| 2018 |
Puyang X, Furman C, Zheng GZ, Wu ZJ, Banka D, Aithal B K, Agoulnik S, Bolduc DM, Buonamici S, Caleb B, Das S, Eckley S, Fekkes P, Hao MH, Hart A, ... ... Thomas M, et al. Discovery of Selective Estrogen Receptor Covalent Antagonists (SERCAs) for the treatment of ERa(WT) and ERa(MUT) breast cancer. Cancer Discovery. PMID 29991605 DOI: 10.1158/2159-8290.Cd-17-1229 |
0.099 |
|
| 2017 |
Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, et al. nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy. Lung Cancer (Auckland, N.Z.). 8: 207-216. PMID 29138610 DOI: 10.2147/LCTT.S138570 |
0.099 |
|
| 2021 |
Cook JA, Baldwin M, Cooper C, Nagra NS, Crocker JC, Glaze M, Greenall G, Rangan A, Kottam L, Rees JL, Farrar-Hockley D, Merritt N, Hopewell S, Beard D, Thomas M, et al. Findings from the patch augmented rotator cuff surgery (PARCS) feasibility study. Pilot and Feasibility Studies. 7: 163. PMID 34416915 DOI: 10.1186/s40814-021-00899-9 |
0.099 |
|
| 2019 |
Christopoulos P, Dietz S, Kirchner M, Volckmar AL, Endris V, Neumann O, Ogrodnik S, Heussel CP, Herth FJ, Eichhorn M, Meister M, Budczies J, Allgäuer M, Leichsenring J, Zemojtel T, ... ... Thomas M, et al. Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival. Cancers. 11. PMID 30669647 DOI: 10.3390/cancers11010124 |
0.099 |
|
| 2006 |
Hicks AM, DeLong CJ, Thomas MJ, Samuel M, Cui Z. Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry. Biochimica Et Biophysica Acta. 1761: 1022-9. PMID 16860597 DOI: 10.1016/j.bbalip.2006.05.010 |
0.099 |
|
| 2018 |
Heining D, Senior J, Prasad A, Thomas M, Bentall A, Yates PJ. Multi-system bleeding risk with a cutaneous angiosarcoma at an arteriovenous fistula site. Oxford Medical Case Reports. 2018: omy063. PMID 30250745 DOI: 10.1093/omcr/omy063 |
0.098 |
|
| 2024 |
Menzel M, Kirchner M, Kluck K, Ball M, Beck S, Allgäuer M, Assmann C, Schnorbach J, Volckmar AL, Tay TKY, Goldschmid H, Tan DS, Thomas M, Kazdal D, Budczies J, et al. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The Journal of Pathology. Clinical Research. 10: e354. PMID 38284983 DOI: 10.1002/cjp2.354 |
0.098 |
|
| 2023 |
Angeles AK, Janke F, Daum AK, Reck M, Schneider MA, Thomas M, Christopoulos P, Sültmann H. Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma. British Journal of Cancer. PMID 37120670 DOI: 10.1038/s41416-023-02284-0 |
0.098 |
|
| 2014 |
Warth A, Penzel R, Lindenmaier H, Brandt R, Stenzinger A, Herpel E, Goeppert B, Thomas M, Herth FJ, Dienemann H, Schnabel PA, Schirmacher P, Hoffmann H, Muley T, Weichert W. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. The European Respiratory Journal. 43: 872-83. PMID 23988776 DOI: 10.1183/09031936.00018013 |
0.098 |
|
| 2023 |
Deis N, Unsöld L, Siegle A, Krisam J, Thomas M, Villalobos M. HELP - Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial. Trials. 24: 356. PMID 37231417 DOI: 10.1186/s13063-023-07365-2 |
0.098 |
|
| 2020 |
Garon EB, Scagliotti GV, Gautschi O, Reck M, Thomas M, Iglesias Docampo L, Kalofonos H, Kim JH, Gans S, Brustugun OT, Orlov SV, Cuyun Carter G, Zimmermann AH, Oton AB, Alexandris E, et al. Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy. Esmo Open. 5. PMID 31958290 DOI: 10.1136/esmoopen-2019-000567 |
0.098 |
|
| 2018 |
Cook JA, Merritt N, Rees JL, Crocker JC, Hopewell S, Dritsaki M, Beard DJ, Rangan A, Cooper C, Kottam L, Farrar-Hockley D, Thomas M, Earle R, Carr AJ. Patch-augmented rotator cuff surgery (PARCS) study-protocol for a feasibility study. Pilot and Feasibility Studies. 4: 188. PMID 30598834 DOI: 10.1186/s40814-018-0380-7 |
0.098 |
|
| 2006 |
Reinmuth N, Meister M, Muley T, Steins M, Kreuter M, Herth FJ, Hoffmann H, Dienemann H, Thomas M. Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancer. International Journal of Cancer. Journal International Du Cancer. 119: 727-34. PMID 16557579 DOI: 10.1002/ijc.21750 |
0.097 |
|
| 2014 |
Reinmuth N, Stumpf P, Stumpf A, Muley T, Kobinger S, Hoffmann H, Herth FJ, Schnabel PA, Bischoff H, Thomas M. Characteristics of lung cancer after a previous malignancy. Respiratory Medicine. 108: 910-7. PMID 24650574 DOI: 10.1016/j.rmed.2014.02.015 |
0.097 |
|
| 2018 |
Hacken ET, Valentin R, Regis FFD, Sun J, Yin S, Werner L, Deng J, Gruber M, Wong J, Zheng M, Gill AL, Seiler M, Smith P, Thomas M, Buonamici S, et al. Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies. Jci Insight. 3. PMID 30282833 DOI: 10.1172/Jci.Insight.121438 |
0.097 |
|
| 2020 |
Hohmann N, Bozorgmehr F, Christopoulos P, Mikus G, Blank A, Burhenne J, Thomas M, Haefeli WE. Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat. Clinical and Translational Science. PMID 33222380 DOI: 10.1111/cts.12921 |
0.097 |
|
| 2015 |
Dawson D, Cleggett C, Thompson K, Thomas MJ. Fatigue proofing: The role of protective behaviours in mediating fatigue-related risk in a defence aviation environment. Accident; Analysis and Prevention. PMID 26555252 DOI: 10.1016/j.aap.2015.10.011 |
0.097 |
|
| 2021 |
Krug K, Bossert J, Deis N, Krisam J, Villalobos M, Siegle A, Jung C, Hagelskamp L, Unsöld L, Jünger J, Thomas M, Wensing M. Effects of an interprofessional communication approach on support needs, quality of life and mood of advanced lung cancer patients: a randomized trial. The Oncologist. PMID 33860592 DOI: 10.1002/onco.13790 |
0.097 |
|
| 2012 |
Pfannschmidt J, Egerer G, Bischof M, Thomas M, Dienemann H. Surgical intervention for pulmonary metastases. Deutsches Arzteblatt International. 109: 645-51. PMID 23094000 DOI: 10.3238/arztebl.2012.0645 |
0.096 |
|
| 2013 |
Gottschling S, Jensen K, Herth FJ, Thomas M, Schnabel PA, Herpel E. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. Anticancer Research. 33: 981-90. PMID 23482770 |
0.096 |
|
| 2020 |
Spigel DR, Jotte RM, Aix SP, Gressot L, Morgensztern D, McCleod M, Socinski MA, Daniel D, Juan-Vidal O, Mileham KF, West H, Page R, Reinmuth N, Knoble J, Chen T, ... ... Thomas M, et al. Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial. Clinical Lung Cancer. PMID 33097414 DOI: 10.1016/j.cllc.2020.09.007 |
0.096 |
|
| 2016 |
Riediger AL, Dietz S, Schirmer U, Meister M, Heinzmann-Groth I, Schneider M, Muley T, Thomas M, Sültmann H. Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients. Scientific Reports. 6: 33505. PMID 27640882 DOI: 10.1038/srep33505 |
0.096 |
|
| 2021 |
Magios N, Bozorgmehr F, Volckmar AL, Kazdal D, Kirchner M, Herth FJ, Heussel CP, Eichhorn F, Meister M, Muley T, Elshafie RA, Fischer JR, Faehling M, Kriegsmann M, Schirmacher P, ... ... Thomas M, et al. Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer. Therapeutic Advances in Medical Oncology. 13: 1758835921996509. PMID 34408792 DOI: 10.1177/1758835921996509 |
0.096 |
|
| 2021 |
Kuon J, Blasi M, Unsöld L, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, ... ... Thomas M, et al. Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 30: 3131-3140. PMID 34877613 DOI: 10.1007/s00520-021-06736-2 |
0.095 |
|
| 2020 |
Janke F, Bozorgmehr F, Wrenger S, Dietz S, Heussel CP, Heussel G, Silva CF, Rheinheimer S, Feisst M, Thomas M, Golpon H, Günther A, Sültmann H, Muley T, Janciauskiene S, et al. Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages. Cancers. 12. PMID 32290637 DOI: 10.3390/cancers12040954 |
0.095 |
|
| 2023 |
Regnery S, Katsigiannopulos E, Hoegen P, Weykamp F, Sandrini E, Held T, Deng M, Eichkorn T, Buchele C, Rippke C, Renkamp CK, König L, Lang K, Thomas M, Winter H, et al. To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes. Lung Cancer (Amsterdam, Netherlands). 179: 107175. PMID 36965207 DOI: 10.1016/j.lungcan.2023.03.011 |
0.095 |
|
| 2023 |
Christopoulos P, Schlenk R, Kazdal D, Blasi M, Lennerz J, Shah R, Budczies J, Malek N, Fröhling S, Rosenquist R, Schirmacher P, Bozorgmehr F, Kuon J, Reck M, Thomas M, et al. Real-world data for precision cancer medicine - a European perspective. Genes, Chromosomes & Cancer. PMID 36852573 DOI: 10.1002/gcc.23135 |
0.095 |
|
| 2012 |
Warth A, Macher-Goeppinger S, Muley T, Thomas M, Hoffmann H, Schnabel PA, Penzel R, Schirmacher P, Aulmann S. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. The European Respiratory Journal. 39: 1437-42. PMID 22075483 DOI: 10.1183/09031936.00105911 |
0.095 |
|
| 2020 |
Turkowski K, Herzberg F, Günther S, Brunn D, Weigert A, Meister M, Muley T, Kriegsmann M, Schneider MA, Winter H, Thomas M, Grimminger F, Seeger W, Savai Pullamsetti S, Savai R. Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. Cells. 9. PMID 32707902 DOI: 10.3390/cells9081755 |
0.095 |
|
| 2023 |
Ignatius Ou SH, Hong JL, Christopoulos P, Lin HM, Vincent S, Churchill EN, Soeda J, Kazdal D, Stenzinger A, Thomas M. Distribution and Detectability of EGFR Exon 20 Insertion Variants in Non-small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 36738930 DOI: 10.1016/j.jtho.2023.01.086 |
0.095 |
|
| 2018 |
Schuette W, Schirmacher P, Eberhardt WEE, Dietel M, Zirrgiebel U, Muehlenhoff L, Thomas M. Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study. Bmc Cancer. 18: 135. PMID 29402243 DOI: 10.1186/s12885-018-4032-3 |
0.095 |
|
| 2009 |
Reinmuth N, Liersch R, Raedel M, Fehrmann F, Fehrmann N, Bayer M, Schwoeppe C, Kessler T, Berdel W, Thomas M, Mesters RM. Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer. International Journal of Cancer. 124: 1535-44. PMID 19115205 DOI: 10.1002/ijc.24109 |
0.095 |
|
| 2017 |
Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R, Aix SP, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, ... ... Thomas M, et al. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. The Lancet. Respiratory Medicine. PMID 28408243 DOI: 10.1016/S2213-2600(17)30129-7 |
0.094 |
|
| 2011 |
Herpel E, Jensen K, Muley T, Warth A, Schnabel PA, Meister M, Herth FJ, Dienemann H, Thomas M, Gottschling S. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Research. 31: 4491-500. PMID 22199321 |
0.094 |
|
| 2010 |
Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, Bhat S, Gibbs DP, Thomas MJ, Sorci-Thomas MG. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. The Journal of Biological Chemistry. 285: 36158-69. PMID 20833724 DOI: 10.1074/Jbc.M110.134130 |
0.093 |
|
| 2009 |
Thomas M. [How can patient care be improved? Goal: compulsory standards for lung cancer (interview by Dr. Jochen Aumiller)]. Mmw Fortschritte Der Medizin. 151: 16. PMID 19728673 |
0.093 |
|
| 2016 |
Schiergens TS, Lüning J, Renz BW, Thomas M, Pratschke S, Feng H, Lee SM, Engel J, Rentsch M, Guba M, Werner J, Thasler WE. Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer? Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 26921025 DOI: 10.1007/s11605-016-3115-1 |
0.093 |
|
| 2014 |
Gridelli C, de Marinis F, Thomas M, Prabhash K, El Kouri C, Blackhall F, Bustin F, Pujol JL, John WJ, San Antonio B, Zimmermann A, Chouaki N, Visseren-Grul C, Paz-Ares LG. Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 991-7. PMID 24926544 DOI: 10.1097/JTO.0000000000000207 |
0.093 |
|
| 2016 |
Dietz S, Schirmer U, Mercé C, von Bubnoff N, Dahl E, Meister M, Muley T, Thomas M, Sültmann H. Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients. Plos One. 11: e0161012. PMID 27529345 DOI: 10.1371/journal.pone.0161012 |
0.092 |
|
| 2018 |
Melnik S, Dvornikov D, Müller-Decker K, Depner S, Stannek P, Meister M, Warth A, Thomas M, Muley T, Risch A, Plass C, Klingmüller U, Niehrs C, Glinka A. Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification. Cell Discovery. 4: 37. PMID 29977599 DOI: 10.1038/S41421-018-0033-2 |
0.092 |
|
| 2012 |
Bowlby SC, Thomas MJ, D'Agostino RB, Kridel SJ. Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells. Plos One. 7: e40195. PMID 22768255 DOI: 10.1371/Journal.Pone.0040195 |
0.091 |
|
| 2006 |
Baumann M, Dienemann HC, Fietkau R, Rübe C, Thomas M. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)]. Onkologie. 11-4. PMID 16974122 DOI: 10.1159/000094949 |
0.091 |
|
| 2022 |
Klotz LV, Hoffmann H, Shah R, Eichhorn F, Gruenewald C, Bulut EL, Griffo R, Muley T, Christopoulos P, Baum P, Huber P, Safi S, Kriegsmann M, Thomas M, Bischoff H, et al. Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach. Translational Lung Cancer Research. 11: 2230-2242. PMID 36519024 DOI: 10.21037/tlcr-22-199 |
0.091 |
|
| 2015 |
Klimley AP, Chapman ED, Cech JJ, Cocherell DE, Fangue NA, Gingras M, Jackson Z, Miller EA, Mora EA, Poletto JB, Schreier AM, Seesholtz A, Sulak KJ, Thomas MJ, Woodbury D, et al. Sturgeon in the Sacramento-San Joaquin watershed: New insights to support conservation and management San Francisco Estuary and Watershed Science. 13: 1-17. DOI: 10.15447/Sfews.2015V13Iss4Art1 |
0.091 |
|
| 2012 |
Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1438-46. PMID 22393100 DOI: 10.1200/JCO.2011.37.2185 |
0.091 |
|
| 2013 |
Reinmuth N, Stumpf A, Stumpf P, Muley T, Kobinger S, Hoffmann H, Herth FJ, Schnabel PA, Warth A, Bischoff H, Thomas M. Characteristics and outcome of patients with second primary lung cancer. The European Respiratory Journal. 42: 1668-76. PMID 23060634 DOI: 10.1183/09031936.00022512 |
0.091 |
|
| 2011 |
Rothwell PE, Kourrich S, Thomas MJ. Environmental novelty causes stress-like adaptations at nucleus accumbens synapses: implications for studying addiction-related plasticity. Neuropharmacology. 61: 1152-9. PMID 21315090 DOI: 10.1016/j.neuropharm.2011.01.038 |
0.09 |
|
| 2017 |
Haun MW, Estel S, Rücker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. The Cochrane Database of Systematic Reviews. 6: CD011129. PMID 28603881 DOI: 10.1002/14651858.CD011129.pub2 |
0.09 |
|
| 2014 |
Ghosh S, Ucer KB, D'Agostino R, Grant K, Sirintrapun J, Thomas MJ, Hantgan R, Bharadwaj M, Gmeiner WH. Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 451-61. PMID 23988714 DOI: 10.1016/J.Nano.2013.07.019 |
0.09 |
|
| 2011 |
Gottschling S, Penzel R, Pelz T, Herpel E, Schnabel PA, Dyckhoff G, Thomas M, Kuhnt T. KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib: a case report and review of the literature. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e616-9. PMID 21555681 DOI: 10.1200/JCO.2011.34.5892 |
0.09 |
|
| 2018 |
Seiler M, Yoshimi A, Darman R, Chan B, Keaney G, Thomas M, Agrawal AA, Caleb B, Csibi A, Sean E, Fekkes P, Karr C, Klimek V, Lai G, Lee L, et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nature Medicine. PMID 29457796 DOI: 10.1038/Nm.4493 |
0.09 |
|
| 2013 |
Gottschling S, Jensen K, Warth A, Herth FJ, Thomas M, Schnabel PA, Herpel E. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis. The European Respiratory Journal. 41: 656-63. PMID 22743677 DOI: 10.1183/09031936.00225711 |
0.089 |
|
| 2004 |
Karmiloff-Smith A, Thomas M, Annaz D, Humphreys K, Ewing S, Brace N, Duuren M, Pike G, Grice S, Campbell R. Exploring the Williams syndrome face-processing debate: the importance of building developmental trajectories. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 45: 1258-74. PMID 15335346 DOI: 10.1111/J.1469-7610.2004.00322.X |
0.089 |
|
| 2011 |
Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. Thyroid : Official Journal of the American Thyroid Association. 21: 335-46. PMID 21417738 DOI: 10.1089/thy.2010.0403 |
0.089 |
|
| 2021 |
Cook JA, Baldwin M, Cooper C, Nagra NS, Crocker JC, Glaze M, Greenall G, Rangan A, Kottam L, Rees JL, Farrar-Hockley D, Merritt N, Hopewell S, Beard D, Thomas M, et al. Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study. Health Technology Assessment (Winchester, England). 25: 1-138. PMID 33646096 DOI: 10.3310/hta25130 |
0.088 |
|
| 2015 |
Gross AL, Mungas DM, Crane PK, Gibbons LE, MacKay-Brandt A, Manly JJ, Mukherjee S, Romero H, Sachs B, Thomas M, Potter GG, Jones RN. Effects of Education and Race on Cognitive Decline: An Integrative Study of Generalizability Versus Study-Specific Results. Psychology and Aging. PMID 26523693 DOI: 10.1037/Pag0000032 |
0.088 |
|
| 2014 |
Hülsmann HJ, Rolff J, Bender C, Jarahian M, Korf U, Herwig R, Fröhlich H, Thomas M, Merk J, Fichtner I, Sültmann H, Kuner R. Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib. Lung Cancer (Amsterdam, Netherlands). 86: 151-7. PMID 25240516 DOI: 10.1016/j.lungcan.2014.09.001 |
0.088 |
|
| 2023 |
El Ghali A, Morrisette T, Alosaimy S, Lucas K, Tupayachi-Ortiz MG, Vemula R, Wadle C, Philley JV, Mejia-Chew C, Hamad Y, Stevens RW, Zeuli JD, Webb AJ, Fiske CT, Simonyan A, ... ... Thomas M, et al. Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes. Antimicrobial Agents and Chemotherapy. e0082423. PMID 37768312 DOI: 10.1128/aac.00824-23 |
0.087 |
|
| 2010 |
Gatzemeier U, Griesinger F, Huber RM, Thomas M. [Local and systemic therapy of non-small cell lung carcinoma (NSCLC)]. Onkologie. 33: 1. PMID 20523100 DOI: 10.1159/000313970 |
0.087 |
|
| 2021 |
Baum P, Taber S, Erdmann S, Muley T, Kriegsmann M, Christopoulos P, Thomas M, Winter H, Pfannschmidt J, Eichhorn ME. Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition. Cancers. 13. PMID 33920161 DOI: 10.3390/cancers13081812 |
0.087 |
|
| 2023 |
Goldschmid H, Kluck K, Ball M, Kirchner M, Allgäuer M, Winter H, Herth F, Heußel CP, Pullamsetti SS, Savai R, Yong TTK, Schirmacher P, Peters S, Thomas M, Christopoulos P, et al. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas. Lung Cancer (Amsterdam, Netherlands). 180: 107212. PMID 37141769 DOI: 10.1016/j.lungcan.2023.107212 |
0.087 |
|
| 2017 |
Thomas MJ, Bartlett HL, Bassetti MF, Lubner SJ, Kirvassilis G, Anagnostopoulos PV, Maloney JD, Macke RA. Minimally Invasive Esophagectomy in a Patient With Tetralogy of Fallot and Right-Sided Aortic Arch. The Annals of Thoracic Surgery. 103: e77-e79. PMID 28007281 DOI: 10.1016/j.athoracsur.2016.06.092 |
0.087 |
|
| 2022 |
Rajakumar T, Horos R, Jehn J, Schenz J, Muley T, Pelea O, Hofmann S, Kittner P, Kahraman M, Heuvelman M, Sikosek T, Feufel J, Skottke J, Nötzel D, Hinkfoth F, ... ... Thomas M, et al. A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy. Npj Precision Oncology. 6: 19. PMID 35361874 DOI: 10.1038/s41698-022-00262-y |
0.087 |
|
| 2015 |
Jedynak J, Hearing M, Ingebretson A, Ebner SR, Kelly M, Fischer RA, Kourrich S, Thomas MJ. Cocaine and Amphetamine Induce Overlapping but Distinct Patterns of AMPAR Plasticity in Nucleus Accumbens Medium Spiny Neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26068728 DOI: 10.1038/Npp.2015.168 |
0.087 |
|
| 2016 |
Leichsenring J, Volckmar AL, Magios N, de Oliveira CM, Penzel R, Brandt R, Kirchner M, Bozorgmehr F, Thomas M, Schirmacher P, Warth A, Endris V, Stenzinger A. Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma. Genes, Chromosomes & Cancer. PMID 27750395 DOI: 10.1002/gcc.22427 |
0.087 |
|
| 2002 |
Broermann P, Junker K, Brandt BH, Heinecke A, Freitag L, Klinke F, Berdel WE, Thomas M. Trimodality treatment in Stage III nonsmall cell lung carcinoma: prrognostic impact of K-ras mutations after neoadjuvant therapy. Cancer. 94: 2055-62. PMID 11932909 DOI: 10.1002/cncr.10387 |
0.086 |
|
| 2018 |
Hay S, Kulkarni R, Watts A, Stanley D, Trail I, Van Rensburg L, Little C, Samdanis V, Jenkins P, Eames M, Phadnis J, Ali A, Rangan A, Drew S, Amirfeyz R, ... ... Thomas M, et al. The Provision of Primary and Revision Elbow Replacement Surgery in the NHS. Shoulder & Elbow. 10: S5-S12. PMID 30147752 DOI: 10.1177/1758573218789849 |
0.086 |
|
| 2016 |
Lertkiatmongkol P, Paddock C, Newman DK, Zhu J, Thomas MJ, Newman PJ. The role of sialylated glycans in human PECAM-1-mediated trans-homophilic interactions and endothelial cell barrier function. The Journal of Biological Chemistry. PMID 27793989 DOI: 10.1074/Jbc.M116.756502 |
0.086 |
|
| 2007 |
Meister M, Schirmacher P, Dienemann H, Mechtersheimer G, Schnabel PA, Kern MA, Herpel E, Xu EC, Muley T, Thomas M, Rieker RJ. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Letters. 248: 186-91. PMID 16919868 DOI: 10.1016/j.canlet.2006.07.003 |
0.086 |
|
| 2017 |
Schmidt LH, Stucke-Ring J, Brand C, Schliemann C, Harrach S, Muley T, Herpel E, Kessler T, Mohr M, Görlich D, Kreuter M, Lenz G, Wardelmann E, Thomas M, Berdel WE, et al. CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 113: 121-127. PMID 29110838 DOI: 10.1016/j.lungcan.2017.09.013 |
0.086 |
|
| 2017 |
Wehler T, Thomas M, Schumann C, Bosch-Barrera J, Viñolas Segarra N, Dickgreber NJ, Dalhoff K, Sebastian M, Corral Jaime J, Alonso M, Hynes SM, Lin J, Hurt K, Bence Lin A, Calvo E, et al. A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 108: 212-216. PMID 28625637 DOI: 10.1016/j.lungcan.2017.03.001 |
0.085 |
|
| 2023 |
Walter J, Kauffmann-Guerrero D, Muley T, Reck M, Fuge J, Günther A, Majeed RW, Savai R, Koch I, Dinkel J, Schneider C, Senghas K, Kobinger S, Manapov F, Thomas M, et al. Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients. Cancer Medicine. PMID 36707972 DOI: 10.1002/cam4.5638 |
0.085 |
|
| 2009 |
Dickgreber NJ, Fink TH, Latz JE, Hossain AM, Musib LC, Thomas M. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 382-9. PMID 19118069 DOI: 10.1158/1078-0432.CCR-08-0128 |
0.085 |
|
| 2004 |
Thomas M, Keramidas M, Monchaux E, Feige JJ. Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. Endocrinology. 145: 4320-9. PMID 15178648 DOI: 10.1210/en.2004-0179 |
0.085 |
|
| 2015 |
Devasthale P, Wang W, Mignone J, Renduchintala K, Radhakrishnan S, Dhanapal J, Selvaraj J, Kuppusamy R, Pelleymounter MA, Longhi D, Huang N, Flynn N, Azzara AV, Rohrbach K, Devenny J, ... ... Thomas M, et al. Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies. Bioorganic & Medicinal Chemistry Letters. PMID 26386604 DOI: 10.1016/j.bmcl.2015.09.018 |
0.085 |
|
| 2018 |
Allgäuer M, Budczies J, Christopoulos P, Endris V, Lier A, Rempel E, Volckmar AL, Kirchner M, von Winterfeld M, Leichsenring J, Neumann O, Fröhling S, Penzel R, Thomas M, Schirmacher P, et al. Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians. Translational Lung Cancer Research. 7: 703-715. PMID 30505715 DOI: 10.21037/tlcr.2018.08.14 |
0.085 |
|
| 2010 |
Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1706-13. PMID 20871269 DOI: 10.1097/JTO.0b013e3181f1c8de |
0.085 |
|
| 2006 |
Fukushima T, Zapata JM, Singha NC, Thomas M, Kress CL, Krajewska M, Krajewski S, Ronai Z, Reed JC, Matsuzawa SI. Critical function for SIP, a ubiquitin E3 ligase component of the β-catenin degradation pathway, for thymocyte development and G1 checkpoint Immunity. 24: 29-39. PMID 16413921 DOI: 10.1016/J.Immuni.2005.12.002 |
0.084 |
|
| 2015 |
Pena G, Altree M, Field J, Thomas MJ, Hewett P, Babidge W, Maddern GJ. Surgeons' and trainees' perceived self-efficacy in operating theatre non-technical skills. The British Journal of Surgery. 102: 708-15. PMID 25790065 DOI: 10.1002/bjs.9787 |
0.084 |
|
| 2020 |
Swerdlow NR, Bhakta S, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas M, Joshi Y, Molina JL, Light GA. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32961542 DOI: 10.1038/s41386-020-00865-8 |
0.084 |
|
| 2019 |
Campbell JD, Perry R, Papadopoulos NG, Krishnan J, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Quint J, Price D, Roche N. The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies. Clinical and Translational Allergy. 9: 21. PMID 30962876 DOI: 10.1186/s13601-019-0256-9 |
0.084 |
|
| 2004 |
Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1944-8. PMID 15143088 DOI: 10.1200/JCO.2004.10.002 |
0.083 |
|
| 2013 |
Muley T, Dienemann H, Herth FJ, Thomas M, Meister M, Schneider J. Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 947-51. PMID 23777840 DOI: 10.1097/JTO.0b013e31828f696b |
0.083 |
|
| 2018 |
Titz C, Hummler S, Schmidt ME, Thomas M, Steins M, Wiskemann J. Exercise behavior and physical fitness in patients with advanced lung cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29480444 DOI: 10.1007/s00520-018-4105-5 |
0.083 |
|
| 2023 |
Griesinger F, Sebastian M, Brueckl WM, Hummel HD, Jaeschke B, Kern J, Wesseler C, Jänicke M, Fleitz A, Zacharias S, Hipper A, Groth A, Weichert W, Dörfel S, Petersen V, ... ... Thomas M, et al. Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315). Jto Clinical and Research Reports. 5: 100626. PMID 38586301 DOI: 10.1016/j.jtocrr.2023.100626 |
0.083 |
|
| 2022 |
Merz EC, Strack J, Hurtado H, Vainik U, Thomas M, Evans A, Khundrakpam B. Educational attainment polygenic scores, socioeconomic factors, and cortical structure in children and adolescents. Human Brain Mapping. PMID 35894163 DOI: 10.1002/hbm.26034 |
0.082 |
|
| 2014 |
Washburn WN, Manfredi M, Devasthale P, Zhao G, Ahmad S, Hernandez A, Robl JA, Wang W, Mignone J, Wang Z, Ngu K, Pelleymounter MA, Longhi D, Zhao R, Wang B, ... ... Thomas M, et al. Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate. Journal of Medicinal Chemistry. 57: 7509-22. PMID 25165888 DOI: 10.1021/jm500026w |
0.082 |
|
| 2016 |
Hu W, Zhang W, Chen Y, Rana U, Teng RJ, Duan Y, Liu Z, Zhao B, Foeckler J, Weiler H, Kallinger RE, Thomas MJ, Zhang K, Han J, Robert Miao Q. Nogo-B receptor deficiency increases LXRα nuclear translocation and hepatic lipogenesis via an AMPKα-dependent pathway. Hepatology (Baltimore, Md.). PMID 27480224 DOI: 10.1002/hep.28747 |
0.082 |
|
| 2019 |
Villalobos M, Siegle A, Hagelskamp L, Jung C, Thomas M. Communication along Milestones in Lung Cancer Patients with Advanced Disease. Oncology Research and Treatment. 42. PMID 30677754 DOI: 10.1159/000496407 |
0.082 |
|
| 2020 |
Bossert J, Wensing M, Thomas M, Villalobos M, Jung C, Siegle A, Hagelskamp L, Deis N, Jünger J, Krug K. Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity. Bmc Palliative Care. 19: 21. PMID 32070311 DOI: 10.1186/s12904-020-0527-1 |
0.081 |
|
| 2018 |
Siegle A, Villalobos M, Bossert J, Krug K, Hagelskamp L, Krisam J, Handtke V, Deis N, Jünger J, Wensing M, Thomas M. The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials. 19: 438. PMID 30107809 DOI: 10.1186/s13063-018-2814-1 |
0.081 |
|
| 2013 |
Thomas M, Rentsch M, Drefs M, Andrassy J, Meiser B, Stangl M, Jauch KW, Guba M. Impact of surgical training and surgeon's experience on early outcome in kidney transplantation. Langenbeck's Archives of Surgery / Deutsche Gesellschaft FüR Chirurgie. 398: 581-5. PMID 23519904 DOI: 10.1007/s00423-013-1073-6 |
0.081 |
|
| 2021 |
Wang Y, Siesel C, Chen Y, Lopman B, Edison L, Thomas M, Adams C, Lau M, Teunis PFM. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Georgia, USA, February 1-July 13, 2020. Emerging Infectious Diseases. 27. PMID 34399085 DOI: 10.3201/eid2710.210061 |
0.081 |
|
| 2022 |
Malona J, Chuaqui C, Seletsky BM, Beebe L, Cantin S, van Kalken D, Fahnoe K, Wang Z, Browning B, Szabo H, Koopman LA, Oravecz T, McDonald JJ, Ramirez-Valle F, Gaur R, ... ... Thomas M, et al. Discovery of CC-99677, a Selective Targeted Covalent MAPKAPK2 (MK2) Inhibitor for Autoimmune Disorders. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 35691544 DOI: 10.1016/j.trsl.2022.06.005 |
0.08 |
|
| 2007 |
Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, Csizmadia E, Usheva A, Margreiter R, Bach FH. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle (Georgetown, Tex.). 6: 39-43. PMID 17245120 DOI: 10.4161/cc.6.1.3700 |
0.08 |
|
| 2004 |
Edwards IJ, Berquin IM, Sun H, O'flaherty JT, Daniel LW, Thomas MJ, Rudel LL, Wykle RL, Chen YQ. Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8275-83. PMID 15623603 DOI: 10.1158/1078-0432.Ccr-04-1357 |
0.08 |
|
| 2008 |
Ollinger R, Thomas M, Kogler P, Hermann M, Weiss H, Mark W, Bilban M, Troppmair J, Bach FH, Margreiter R. Blockade of p38 MAPK inhibits chronic allograft vasculopathy. Transplantation. 85: 293-7. PMID 18212636 DOI: 10.1097/TP.0b013e318160130f |
0.08 |
|
| 2003 |
Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 22: 8031-41. PMID 12970751 DOI: 10.1038/sj.onc.1206928 |
0.079 |
|
| 2015 |
Giordano JO, Thomas MJ, Catucuamba G, Curler MD, Wijma R, Stangaferro ML, Masello M. Effect of extending the interval from Presynch to initiation of Ovsynch in a Presynch-Ovsynch protocol on fertility of timed artificial insemination services in lactating dairy cows. Journal of Dairy Science. PMID 26506551 DOI: 10.3168/Jds.2015-10083 |
0.079 |
|
| 2017 |
Sorci-Thomas MG, Thomas MJ. AIBP, NAXE, and Angiogenesis: What's in a Name? Circulation Research. 120: 1690-1691. PMID 28546345 DOI: 10.1161/Circresaha.117.311023 |
0.079 |
|
| 2019 |
Datta RR, Dieplinger G, Wahba R, Kleinert R, Thomas M, Gebauer F, Schiffmann L, Stippel DL, Bruns CJ, Fuchs HF. True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available device. Surgical Endoscopy. PMID 31659506 DOI: 10.1007/s00464-019-07229-4 |
0.079 |
|
| 2014 |
Haun MW, Sklenarova H, Villalobos M, Thomas M, Brechtel A, Löwe B, Herzog W, Hartmann M. Depression, anxiety and disease-related distress in couples affected by advanced lung cancer. Lung Cancer (Amsterdam, Netherlands). 86: 274-80. PMID 25294732 DOI: 10.1016/j.lungcan.2014.09.009 |
0.079 |
|
| 2023 |
Chiapponi C, Faust M, Schmidt M, Schier R, Thomas M, Stippel DL, Bruns CJ, Alakus H. The Impact of the COVID Pandemic on Adrenal Surgery at an Academic Endocrine Surgery Unit. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 55: 765-770. PMID 37903497 DOI: 10.1055/a-2187-3547 |
0.079 |
|
| 2020 |
Gahr S, Lödel S, Berendt J, Thomas M, Ostgathe C. Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers. The Oncologist. 25: e259-e265. PMID 32043783 DOI: 10.1634/theoncologist.2019-0126 |
0.079 |
|
| 2006 |
Joffe D, Elrefai A, Thomas M. Fatal marrow emboli in a pediatric patient having posterior spinal instrumentation for scoliosis repair. Paediatric Anaesthesia. 16: 89-91. PMID 16409538 DOI: 10.1111/j.1460-9592.2005.01612.x |
0.079 |
|
| 2023 |
Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial. Bmc Cancer. 23: 740. PMID 37563548 DOI: 10.1186/s12885-023-11270-x |
0.079 |
|
| 2016 |
Sorci-Thomas MG, Thomas MJ. Microdomains, Inflammation, and Atherosclerosis. Circulation Research. 118: 679-91. PMID 26892966 DOI: 10.1161/Circresaha.115.306246 |
0.078 |
|
| 2005 |
Freiwald M, Valotis A, Kirschbaum A, McClellan M, Mürdter T, Fritz P, Friedel G, Thomas M, Högger P. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Respiratory Research. 6: 21. PMID 15727687 DOI: 10.1186/1465-9921-6-21 |
0.078 |
|
| 1999 |
DeLong CJ, Shen YJ, Thomas MJ, Cui Z. Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. The Journal of Biological Chemistry. 274: 29683-8. PMID 10514439 DOI: 10.1074/jbc.274.42.29683 |
0.078 |
|
| 2023 |
Marks D, Thomas M, Newans T, Bisset L. Immediate response to injection is associated with conservative care outcomes at 12 weeks in subacromial shoulder pain. Musculoskeletal Science & Practice. 64: 102726. PMID 36804722 DOI: 10.1016/j.msksp.2023.102726 |
0.078 |
|
| 2007 |
Witzenrath M, Gutbier B, Owen JS, Schmeck B, Mitchell TJ, Mayer K, Thomas MJ, Ishii S, Rosseau S, Suttorp N, Schütte H. Role of platelet-activating factor in pneumolysin-induced acute lung injury. Critical Care Medicine. 35: 1756-62. PMID 17522574 DOI: 10.1097/01.Ccm.0000269212.84709.23 |
0.078 |
|
| 2012 |
Warth A, Penzel R, Brandt R, Sers C, Fischer JR, Thomas M, Herth FJ, Dietel M, Schirmacher P, Bläker H. Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Archiv : An International Journal of Pathology. 460: 407-14. PMID 22419261 DOI: 10.1007/s00428-012-1219-x |
0.078 |
|
| 2024 |
Bataille Backer P, Adekiya TA, Kim Y, Reid TR, Thomas M, Adesina SK. Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma. Acs Omega. 9: 2615-2628. PMID 38250376 DOI: 10.1021/acsomega.3c07486 |
0.078 |
|
| 2021 |
Regnery S, Buchele C, Weykamp F, Pohl M, Hoegen P, Eichkorn T, Held T, Ristau J, Rippke C, König L, Thomas M, Winter H, Adeberg S, Debus J, Klüter S, et al. Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations. Frontiers in Oncology. 11: 757031. PMID 35087746 DOI: 10.3389/fonc.2021.757031 |
0.077 |
|
| 2021 |
Busshoff J, Datta RR, Bruns T, Kleinert R, Morgenstern B, Pfister D, Chiapponi C, Fuchs HF, Thomas M, Gietzelt C, Hedergott A, Möller D, Hellmich M, Bruns CJ, Stippel DL, et al. Gender benefit in laparoscopic surgical performance using a 3D-display system: data from a randomized cross-over trial. Surgical Endoscopy. PMID 34750707 DOI: 10.1007/s00464-021-08785-4 |
0.077 |
|
| 2023 |
Rostoft S, Thomas MJ, Slaaen M, Møller B, Nesbakken A, Syse A. Hospital use and cancer treatment by age and socioeconomic status in the last year of life: A Norwegian population-based study of patients dying of cancer. Journal of Geriatric Oncology. 15: 101683. PMID 38065011 DOI: 10.1016/j.jgo.2023.101683 |
0.077 |
|
| 2020 |
Berghoff AS, Breckwoldt MO, Riedemann L, Karimian-Jazi K, Loew S, Schlieter F, Furtner J, Cinci M, Thomas M, Strowitzki MJ, Marmé F, Michel LL, Schmidt T, Jäger D, Bendszus M, et al. Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases. Neuro-Oncology Advances. 2: vdaa038. PMID 32642693 DOI: 10.1093/noajnl/vdaa038 |
0.076 |
|
| 2019 |
Aveledo R, Holland P, Thomas M, Ashton F, Rangan A. A comparison of the minimum data sets for primary shoulder arthroplasty between national shoulder arthroplasty registries. Is international harmonization feasible? Shoulder & Elbow. 11: 48-55. PMID 31447945 DOI: 10.1177/1758573218755569 |
0.076 |
|
| 2011 |
Schukken YH, Bennett GJ, Zurakowski MJ, Sharkey HL, Rauch BJ, Thomas MJ, Ceglowski B, Saltman RL, Belomestnykh N, Zadoks RN. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis. Journal of Dairy Science. 94: 6203-15. PMID 22118109 DOI: 10.3168/Jds.2011-4290 |
0.076 |
|
| 2022 |
Thomas M, Wahba R, Chiapponi C, Stippel DL, Bruns C. [Incidental Finding of Appendiceal Neuroendocrine Tumour]. Zentralblatt Fur Chirurgie. 147: 244-248. PMID 35705085 DOI: 10.1055/a-1798-0646 |
0.076 |
|
| 2003 |
Hornsby PJ, Chen M, Hawks CL, Huang Q, Sun B, Wang L, Thomas M. Using cell transplantation to investigate genes involved in aging. Mechanisms of Ageing and Development. 124: 79-84. PMID 12618009 |
0.076 |
|
| 2021 |
Thomas M, Brand S, De Rycker M, Zuccotto F, Lukac I, Dodd PG, Ko EJ, Manthri S, McGonagle K, Osuna-Cabello M, Riley J, Pont C, Simeons F, Stojanovski L, Thomas J, et al. Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of Medicinal Chemistry. PMID 33904304 DOI: 10.1021/acs.jmedchem.1c00047 |
0.076 |
|
| 2004 |
Bhat S, Zabalawi M, Willingham MC, Shelness GS, Thomas MJ, Sorci-Thomas MG. Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions. Journal of Lipid Research. 45: 1207-20. PMID 15060083 DOI: 10.1194/Jlr.M300498-Jlr200 |
0.076 |
|
| 2008 |
Chiesa OA, von Bredow J, Smith M, Thomas M. One-port video assisted laparoscopic kidney biopsy in standing steers. Research in Veterinary Science. 87: 133-4. PMID 19081120 DOI: 10.1016/j.rvsc.2008.10.016 |
0.076 |
|
| 2016 |
Alt-Epping B, Seidel W, Vogt J, Mehnert A, Thomas M, van Oorschot B, Wolff H, Schliephake H, Canis M, Dröge LH, Nauck F, Lordick F. Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study. Oncology Research and Treatment. 39: 186-91. PMID 27160588 DOI: 10.1159/000445307 |
0.076 |
|
| 2021 |
Kriegsmann K, Zgorzelski C, Muley T, Christopoulos P, Thomas M, Winter H, Eichhorn M, Eichhorn F, von Winterfeld M, Herpel E, Goeppert B, Stenzinger A, Herth FJF, Warth A, Kriegsmann M. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples. Bmc Cancer. 21: 486. PMID 33933015 DOI: 10.1186/s12885-021-08140-9 |
0.076 |
|
| 2021 |
Le X, Sakai H, Felip E, Veillon R, Garassino MC, Raskin J, Cortot AB, Viteri S, Mazieres J, Smit EF, Thomas M, Iams WT, Cho BC, Kim HR, Yang JC, et al. Tepotinib Efficacy and Safety in Patients with Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34789481 DOI: 10.1158/1078-0432.CCR-21-2733 |
0.076 |
|
| 2016 |
Andrassy J, Wolf S, Hoffmann V, Rentsch M, Stangl M, Thomas M, Pratschke S, Frey L, Gerbes A, Meiser B, Angele M, Werner J, Guba M. Rescue management of early complications after liver transplantation-key for the long-term success. Langenbeck's Archives of Surgery / Deutsche Gesellschaft Fur Chirurgie. PMID 26960592 DOI: 10.1007/s00423-016-1398-z |
0.075 |
|
| 2012 |
Youm YH, Kanneganti TD, Vandanmagsar B, Zhu X, Ravussin A, Adijiang A, Owen JS, Thomas MJ, Francis J, Parks JS, Dixit VD. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Reports. 1: 56-68. PMID 22832107 DOI: 10.1016/J.Celrep.2011.11.005 |
0.075 |
|
| 2012 |
Dawson D, Chapman J, Thomas MJ. Fatigue-proofing: a new approach to reducing fatigue-related risk using the principles of error management. Sleep Medicine Reviews. 16: 167-75. PMID 21784677 DOI: 10.1016/j.smrv.2011.05.004 |
0.075 |
|
| 2006 |
Croxton R, Puto LA, De Belle I, Thomas M, Torii S, Hanaii F, Cuddy M, Reed JC. Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-κB Cancer Research. 66: 9026-9035. PMID 16982744 DOI: 10.1158/0008-5472.CAN-06-1047 |
0.075 |
|
| 2022 |
Rostoft S, Thomas MJ, Slaaen M, Møller B, Syse A. The effect of age on specialized palliative care use in the last year of life for patients who die of cancer: A nationwide study from Norway. Journal of Geriatric Oncology. 13: 1103-1110. PMID 35973916 DOI: 10.1016/j.jgo.2022.08.002 |
0.075 |
|
| 2016 |
Lefebvre H, Thomas M, Duparc C, Bertherat J, Louiset E. Role of ACTH in the Interactive/Paracrine Regulation of Adrenal Steroid Secretion in Physiological and Pathophysiological Conditions. Frontiers in Endocrinology. 7: 98. PMID 27489549 DOI: 10.3389/fendo.2016.00098 |
0.075 |
|
| 2010 |
Rothwell PE, Gewirtz JC, Thomas MJ. Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2579-89. PMID 20811341 DOI: 10.1038/npp.2010.134 |
0.075 |
|
| 2022 |
Ye Y, Gaudy A, Thomas M, Reyes J, Burkhardt B, Horan G, Liu L, Chen J, Ghosh A, Carayannopoulos LN, Tatosian DA, Palmisano M. Safety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants. Clinical Pharmacology in Drug Development. PMID 36256505 DOI: 10.1002/cpdd.1178 |
0.075 |
|
| 2020 |
Regnery S, Eichkorn T, Weykamp F, Held T, Weusthof K, Dinges LA, El-Shafie RA, Winter H, Thomas M, Debus J, Adeberg S, Hörner-Rieber J. Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme. Clinical Lung Cancer. PMID 33281061 DOI: 10.1016/j.cllc.2020.11.003 |
0.075 |
|
| 2021 |
Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel CP, Herth FJ, Winter H, Meister M, Muley T, Goldmann T, Fröhling S, Wermke M, ... ... Thomas M, et al. Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 34125345 DOI: 10.1007/s00262-021-02981-w |
0.075 |
|
| 2014 |
Barrenas F, Palermo RE, Agricola B, Agy MB, Aicher L, Carter V, Flanary L, Green RR, McLain R, Li Q, Lu W, Murnane R, Peng X, Thomas MJ, Weiss JM, et al. Deep transcriptional sequencing of mucosal challenge compartment from rhesus macaques acutely infected with simian immunodeficiency virus implicates loss of cell adhesion preceding immune activation. Journal of Virology. 88: 7962-72. PMID 24807713 DOI: 10.1128/JVI.00543-14 |
0.075 |
|
| 2018 |
Buchhalter I, Rempel E, Endris V, Allgäuer M, Neumann O, Volckmar AL, Kirchner M, Leichsenring J, Lier A, von Winterfeld M, Penzel R, Christopoulos P, Thomas M, Fröhling S, Schirmacher P, et al. Size Matters: Dissecting Key Parameters for Panel-Based Tumor Mutational Burden (TMB) Analysis. International Journal of Cancer. PMID 30238975 DOI: 10.1002/ijc.31878 |
0.074 |
|
| 2014 |
Haun MW, Sklenarova H, Winkler EC, Huber J, Thomas M, Siminoff LA, Woll M, Brechtel A, Herzog W, Hartmann M. Assessing patient-caregiver communication in cancer--a psychometric validation of the Cancer Communication Assessment Tool (CCAT-PF) in a German sample. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 2473-8. PMID 24722779 DOI: 10.1007/S00520-014-2241-0 |
0.074 |
|
| 1997 |
Peuchant E, Delmas-Beauvieux MC, Dubourg L, Thomas MJ, Perromat A, Aparicio M, Clerc M, Combe C. Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radical Biology & Medicine. 22: 313-20. PMID 8958156 DOI: 10.1016/S0891-5849(96)00282-1 |
0.074 |
|
| 2017 |
Melchior JT, Walker RG, Cooke AL, Morris J, Castleberry M, Thompson TB, Jones MK, Song HD, Rye KA, Oda MN, Sorci-Thomas MG, Thomas MJ, Heinecke JW, Mei X, Atkinson D, et al. A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state. Nature Structural & Molecular Biology. PMID 29131142 DOI: 10.1038/Nsmb.3501 |
0.074 |
|
| 2016 |
Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nature Medicine. PMID 27135740 DOI: 10.1038/Nm.4097 |
0.074 |
|
| 2012 |
Brandts CH, Schulz C, Willich N, Steffen B, Hardes J, Gosheger G, Winkelmann W, Serve H, Heinecke A, Berdel WE, Thomas M. Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy. Cancer Chemotherapy and Pharmacology. 69: 613-20. PMID 21947168 DOI: 10.1007/s00280-011-1731-8 |
0.074 |
|
| 2012 |
Scott KE, Wheeler FB, Davis AL, Thomas MJ, Ntambi JM, Seals DF, Kridel SJ. Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis. Plos One. 7: e29761. PMID 22238651 DOI: 10.1371/Journal.Pone.0029761 |
0.074 |
|
| 2013 |
Reinmuth N, Payer N, Muley T, Hoffmann H, Herth FJ, Villalobos M, Thomas M. Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients. Respiratory Research. 14: 139. PMID 24351122 DOI: 10.1186/1465-9921-14-139 |
0.074 |
|
| 2024 |
Fischer AK, Stippel D, Canbay A, Nierhoff D, Thomas M, Best J, Büttner R, Drebber U. COVID-19-associated secondary sclerosing cholangitis with liver transplantation. Virchows Archiv : An International Journal of Pathology. PMID 38526652 DOI: 10.1007/s00428-024-03753-4 |
0.074 |
|
| 2016 |
Marks D, Bisset L, Comans T, Thomas M, Ng SK, O'Leary S, Conaghan PG, Scuffham PA. Increasing Capacity for the Treatment of Common Musculoskeletal Problems: A Non-Inferiority RCT and Economic Analysis of Corticosteroid Injection for Shoulder Pain Comparing a Physiotherapist and Orthopaedic Surgeon. Plos One. 11: e0162679. PMID 27631987 DOI: 10.1371/journal.pone.0162679 |
0.073 |
|
| 2001 |
Alvarez RG, Hunter IS, Suckling CJ, Thomas M, Vitinius U. A novel biotransformation of benzofurans and related compounds catalysed by a chloroperoxidase Tetrahedron. 57: 8581-8587. DOI: 10.1016/S0040-4020(01)00837-7 |
0.073 |
|
| 2015 |
Sorci-Thomas MG, Pollard RD, Thomas MJ. What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport? Current Opinion in Lipidology. 26: 420-5. PMID 26218419 DOI: 10.1097/Mol.0000000000000211 |
0.073 |
|
| 2019 |
Bucher JN, Koenig M, Schoenberg MB, Crispin A, Thomas M, Angele MK, Eser-Valeri D, Gerbes AL, Werner J, Guba MO. Liver transplantation in patients with a history of migration-A German single center comparative analysis. Plos One. 14: e0224116. PMID 31639158 DOI: 10.1371/journal.pone.0224116 |
0.073 |
|
| 2003 |
Thome U, Lazrak A, Chen L, Kirk MC, Thomas MJ, Forman HJ, Matalon S. Novel SIN-1 reactive intermediates modulate chloride secretion across murine airway cells. Free Radical Biology & Medicine. 35: 662-75. PMID 12957658 DOI: 10.1016/S0891-5849(03)00392-7 |
0.073 |
|
| 2022 |
Knaack DA, Sorci-Thomas MG, Thomas MJ, Chen Y, Sahoo D. Regulation of Adipocyte Metabolic Homeostasis by SR-BI and PCPE2. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35553852 DOI: 10.1096/fasebj.2022.36.S1.R4040 |
0.073 |
|
| 2022 |
Duparc C, Camponova P, Roy M, Lefebvre H, Thomas M. Ectopic localization of CYP11B1 and CYP11B2-expressing cells in the normal human adrenal gland. Plos One. 17: e0279682. PMID 36584094 DOI: 10.1371/journal.pone.0279682 |
0.073 |
|
| 2010 |
Jones DN, Thomas MJ, Mandel CJ, Grimm J, Hannaford N, Schultz TJ, Runciman W. Where failures occur in the imaging care cycle: lessons from the radiology events register. Journal of the American College of Radiology : Jacr. 7: 593-602. PMID 20678729 DOI: 10.1016/j.jacr.2010.03.013 |
0.072 |
|
| 2011 |
Thomas MJ, Schultz TJ, Hannaford N, Runciman WB. Mapping the limits of safety reporting systems in health care--what lessons can we actually learn? The Medical Journal of Australia. 194: 635-9. PMID 21692720 |
0.072 |
|
| 2020 |
Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proceedings of the National Academy of Sciences of the United States of America. PMID 32820074 DOI: 10.1073/Pnas.2011802117 |
0.072 |
|
| 2005 |
Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology. 147: 782-90. PMID 16254030 DOI: 10.1210/en.2005-0921 |
0.072 |
|
| 2002 |
Thomas M, Wang X, Hornsby PJ. Human adrenocortical cell xenotransplantation: model of cotransplantation of human adrenocortical cells and 3T3 cells in scid mice to form vascularized functional tissue and prevent adrenal insufficiency. Xenotransplantation. 9: 58-67. PMID 12005105 |
0.072 |
|
| 2016 |
Li Y, Carayannopoulos LN, Thomas M, Palmisano M, Zhou S. Exposure-response analysis to assess the concentration-QTc relationship of CC-122. Clinical Pharmacology : Advances and Applications. 8: 117-25. PMID 27672344 DOI: 10.2147/CPAA.S111867 |
0.072 |
|
| 2004 |
Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, Heindel W, Wormanns D. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. European Radiology. 14: 691-702. PMID 14727146 DOI: 10.1007/s00330-003-2200-5 |
0.072 |
|
| 2017 |
Thomas M, Mumith A, Ghani Y. Imaging of foreign bodies: a radiological conundrum. Bmj Case Reports. 2017. PMID 28978575 DOI: 10.1136/Bcr-2017-219706 |
0.072 |
|
| 2022 |
Rheinheimer S, Christopoulos P, Erdmann S, Saupe J, Golpon H, Vogel-Claussen J, Dinkel J, Thomas M, Heussel CP, Kauczor HU, Heussel G. Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis. Bmc Medical Imaging. 22: 215. PMID 36471318 DOI: 10.1186/s12880-022-00943-x |
0.071 |
|
| 2022 |
Krug K, Bossert J, Möllinger S, Deis N, Unsöld L, Siegle A, Villalobos M, Hagelskamp L, Jung C, Thomas M, Wensing M. Factors related to implementation of an interprofessional communication concept in thoracic oncology: a mixed-methods study. Bmc Palliative Care. 21: 89. PMID 35614425 DOI: 10.1186/s12904-022-00977-6 |
0.071 |
|
| 2012 |
O'Flaherty JT, Hu Y, Wooten RE, Horita DA, Samuel MP, Thomas MJ, Sun H, Edwards IJ. 15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival. Plos One. 7: e45480. PMID 23029040 DOI: 10.1371/Journal.Pone.0045480 |
0.071 |
|
| 2012 |
Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, Aldrich S, Harrington T, Formenty P, Loh EH, Machalaba CC, Thomas MJ, Heymann DL. Ecology of zoonoses: natural and unnatural histories. Lancet. 380: 1936-45. PMID 23200502 DOI: 10.1016/S0140-6736(12)61678-X |
0.071 |
|
| 2015 |
Sklenarova H, Krümpelmann A, Haun MW, Friederich HC, Huber J, Thomas M, Winkler EC, Herzog W, Hartmann M. When do we need to care about the caregiver? Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors. Cancer. 121: 1513-9. PMID 25677095 DOI: 10.1002/cncr.29223 |
0.071 |
|
| 2005 |
Tsui ZC, Chen QR, Thomas MJ, Samuel M, Cui Z. A method for profiling gangliosides in animal tissues using electrospray ionization-tandem mass spectrometry. Analytical Biochemistry. 341: 251-8. PMID 15907870 DOI: 10.1016/j.ab.2005.03.036 |
0.071 |
|
| 2020 |
Samdanis V, Manoharan G, Jordan RW, Watts AC, Jenkins P, Kulkarni R, Thomas M, Rangan A, Hay SM. Indications and outcome in total elbow arthroplasty: A systematic review. Shoulder & Elbow. 12: 353-361. PMID 33093874 DOI: 10.1177/1758573219873001 |
0.071 |
|
| 2017 |
Morshedi M, Thomas M, Tarzia A, Doonan CJ, White NG. Supramolecular anion recognition in water: synthesis of hydrogen-bonded supramolecular frameworks. Chemical Science. 8: 3019-3025. PMID 28451369 DOI: 10.1039/C7Sc00201G |
0.07 |
|
| 2002 |
Hornsby PJ, Yang L, Thomas M. Adrenocortical cell proliferation in a cell transplantation model: the role of SV40 T antigen. Endocrine Research. 28: 777-83. PMID 12530697 |
0.07 |
|
| 2008 |
Reinmuth N, Jauch A, Xu EC, Muley T, Granzow M, Hoffmann H, Dienemann H, Herpel E, Schnabel PA, Herth FJ, Gottschling S, Lahm H, Steins M, Thomas M, Meister M. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer (Amsterdam, Netherlands). 62: 193-201. PMID 18450321 DOI: 10.1016/j.lungcan.2008.03.011 |
0.07 |
|
| 1989 |
Thomas MJ, Hedrick CC. Latex beads as vehicles for the study of free radical processes in phagocytic cells. Basic Life Sciences. 49: 853-6. PMID 2855008 DOI: 10.1007/978-1-4684-5568-7_138 |
0.07 |
|
| 2018 |
Ibrahim EF, Rashid A, Thomas M. Resurfacing hemiarthroplasty of the shoulder for patients with juvenile idiopathic arthritis. Journal of Shoulder and Elbow Surgery. PMID 29567037 DOI: 10.1016/j.jse.2018.02.041 |
0.07 |
|
| 2010 |
Whistance RN, Gilbert R, Fayers P, Longman RJ, Pullyblank A, Thomas M, Blazeby JM. Assessment of body image in patients undergoing surgery for colorectal cancer. International Journal of Colorectal Disease. 25: 369-74. PMID 19953257 DOI: 10.1007/s00384-009-0851-7 |
0.07 |
|
| 2019 |
Kazdal D, Endris V, Allgäuer M, Kriegsmann M, Leichsenring J, Volckmar AL, Harms A, Kirchner M, Kriegsmann K, Neumann O, Brandt R, Talla SB, Rempel E, Ploeger C, von Winterfeld M, ... ... Thomas M, et al. Spatial and temporal heterogeneity of panel-based tumor mutational burden (TMB) in pulmonary adenocarcinoma: separating biology from technical artifacts. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31349062 DOI: 10.1016/J.Jtho.2019.07.006 |
0.07 |
|
| 2015 |
Thomas MJ, Lomonaco JD, Creed RP, Meeks A, Brown BL. Reproductive dependence of a Branchiobdellidan annelid on its crayfish host: Confirmation of a mutualism Crustaceana. 88: 385-396. DOI: 10.1163/15685403-00003418 |
0.07 |
|
| 2023 |
Chen Y, Wyatt D, Attanasio M, Thomas M, Thomas M, He B, Nishii R, Liu L, Shan V, Xue Y, Carayannopoulos LN, Ogasawara K, Krishna G. Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults. Cancer Chemotherapy and Pharmacology. PMID 37955741 DOI: 10.1007/s00280-023-04612-w |
0.069 |
|
| 2015 |
Dawson D, Mayger K, Thomas MJ, Thompson K. Fatigue risk management by volunteer fire-fighters: Use of informal strategies to augment formal policy. Accident; Analysis and Prevention. 84: 92-8. PMID 26322733 DOI: 10.1016/j.aap.2015.06.008 |
0.069 |
|
| 2016 |
Lee MH, Appleton KM, El-Shewy HM, Sorci-Thomas MG, Thomas MJ, Lopes-Virella MF, Luttrell LM, Hammad SM, Klein RL. S1P in HDL Promotes Interaction Between SR-BI and S1PR1 and Activates S1PR1-Mediated Biological Functions: Calcium Flux and S1PR1 Internalization. Journal of Lipid Research. PMID 27881715 DOI: 10.1194/Jlr.M070706 |
0.069 |
|
| 2020 |
Budczies J, Kazdal D, Allgäuer M, Christopoulos P, Rempel E, Pfarr N, Weichert W, Fröhling S, Thomas M, Peters S, Endris V, Schirmacher P, Stenzinger A. Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement. Lung Cancer (Amsterdam, Netherlands). 142: 114-119. PMID 32143116 DOI: 10.1016/j.lungcan.2020.01.019 |
0.069 |
|
| 2013 |
Nawrocki ST, Kelly KR, Smith PG, Espitia CM, Possemato A, Beausoleil SA, Milhollen M, Blakemore S, Thomas M, Berger A, Carew JS. Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3577-90. PMID 23633453 DOI: 10.1158/1078-0432.Ccr-12-3212 |
0.069 |
|
| 2015 |
Thomas MJ, Peat G, Rathod T, Marshall M, Moore A, Menz HB, Roddy E. The epidemiology of symptomatic midfoot osteoarthritis in community-dwelling older adults: cross-sectional findings from the Clinical Assessment Study of the Foot. Arthritis Research & Therapy. 17: 178. PMID 26166410 DOI: 10.1186/s13075-015-0693-3 |
0.069 |
|
| 2022 |
Bernhardt D, König L, Grosu AL, Rieken S, Krieg SM, Wick W, Wiestler B, Schmidt-Graf F, Sahm F, Gempt J, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, et al. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 36038670 DOI: 10.1007/s00066-022-01973-8 |
0.068 |
|
| 2016 |
Xue YJ, Hoffmann M, Tong Z, Wu XI, Vallejo M, Melo B, Ye Y, Thomas M, Liu Y, Weiss D, Surapaneni S. Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction. Bioanalysis. PMID 26805594 DOI: 10.4155/bio.15.241 |
0.068 |
|
| 2018 |
Thomas MJ, Mulder CH, Cooke TJ. Geographical Distances Between Separated Parents: A Longitudinal Analysis. European Journal of Population = Revue Europeenne De Demographie. 34: 463-489. PMID 30310246 DOI: 10.1007/s10680-017-9437-1 |
0.068 |
|
| 2024 |
Adekiya TA, Moore M, Thomas M, Lake G, Hudson T, Adesina SK. Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer. Pharmaceutics. 16. PMID 38258124 DOI: 10.3390/pharmaceutics16010114 |
0.068 |
|
| 2011 |
Penrod RD, Kourrich S, Kearney E, Thomas MJ, Lanier LM. An embryonic culture system for the investigation of striatal medium spiny neuron dendritic spine development and plasticity. Journal of Neuroscience Methods. 200: 1-13. PMID 21672554 DOI: 10.1016/j.jneumeth.2011.05.029 |
0.068 |
|
| 2014 |
Josset L, Tchitchek N, Gralinski LE, Ferris MT, Eisfeld AJ, Green RR, Thomas MJ, Tisoncik-Go J, Schroth GP, Kawaoka Y, Manuel de Villena FP, Baric RS, Heise MT, Peng X, Katze MG. Annotation of long non-coding RNAs expressed in collaborative cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts. Rna Biology. 11: 875-90. PMID 24922324 DOI: 10.4161/Rna.29442 |
0.068 |
|
| 2008 |
Thomas MJ, Bhat S, Sorci-Thomas MG. Three-dimensional models of HDL apoA-I: implications for its assembly and function. Journal of Lipid Research. 49: 1875-83. PMID 18515783 DOI: 10.1194/Jlr.R800010-Jlr200 |
0.068 |
|
| 2021 |
Xu H, Thomas MJ, Kaul S, Kallinger R, Ouweneel AB, Maruko E, Oussaada SM, Jongejan A, Cense HA, Nieuwdorp M, Serlie MJ, Goldberg IJ, Civelek M, Parks BW, Lusis AJ, et al. Pcpe2, a Novel Extracellular Matrix Protein, Regulates Adipocyte SR-BI-Mediated High-Density Lipoprotein Uptake. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA121316615. PMID 34551590 DOI: 10.1161/ATVBAHA.121.316615 |
0.068 |
|
| 2006 |
Thomas MJ, Bhat S, Sorci-Thomas MG. The use of chemical cross-linking and mass spectrometry to elucidate the tertiary conformation of lipid-bound apolipoprotein A-I. Current Opinion in Lipidology. 17: 214-20. PMID 16680024 DOI: 10.1097/01.Mol.0000226111.05060.F4 |
0.067 |
|
| 2015 |
Navratil AR, Vozenilek AE, Cardelli JA, Green JM, Thomas MJ, Sorci-Thomas MG, Orr AW, Woolard MD. Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses. Atherosclerosis. 242: 424-432. PMID 26288136 DOI: 10.1016/J.Atherosclerosis.2015.08.012 |
0.067 |
|
| 2019 |
Ossoli A, Simonelli S, Varrenti M, Morici N, Oliva F, Stucchi M, Gomaraschi M, Strazzella A, Arnaboldi L, Thomas MJ, Sorci-Thomas MG, Corsini A, Veglia F, Franceschini G, Karathanasis SK, et al. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA118311987. PMID 30894011 DOI: 10.1161/Atvbaha.118.311987 |
0.067 |
|
| 1995 |
Thomas MJ. The role of free radicals and antioxidants: how do we know that they are working? Critical Reviews in Food Science and Nutrition. 35: 21-39. PMID 7748477 DOI: 10.1080/10408399509527683 |
0.067 |
|
| 2007 |
Reinmuth N, Rensinghoff S, Raedel M, Fehrmann N, Schwöppe C, Kessler T, Bisping G, Hilberg F, Roth GJ, Berdel W, Thomas M, Mesters RM. Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. International Journal of Oncology. 31: 621-6. PMID 17671690 |
0.067 |
|
| 2018 |
Gaddis DE, Padgett LE, Wu R, McSkimming C, Romines V, Taylor AM, McNamara CA, Kronenberg M, Crotty S, Thomas MJ, Sorci-Thomas MG, Hedrick CC. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nature Communications. 9: 1095. PMID 29545616 DOI: 10.1038/S41467-018-03493-5 |
0.067 |
|
| 2014 |
Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, Portoghese PS. Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects. Journal of Medicinal Chemistry. 57: 6383-92. PMID 24978316 DOI: 10.1021/Jm500159D |
0.067 |
|
| 2020 |
Thomas M, De Rycker M, Wall RJ, Spinks D, Epemolu O, Manthri S, Norval S, Osuna-Cabello M, Patterson S, Riley J, Simeons FRC, Stojanovski L, Thomas J, Thompson S, Naylor C, et al. Identification and optimisation of a series of 8-hydroxy naphthyridines with potent antileishmanial activity: Initial SAR and assessment of activity. Journal of Medicinal Chemistry. PMID 32663005 DOI: 10.1021/Acs.Jmedchem.0C00705 |
0.067 |
|
| 2012 |
Sorci-Thomas MG, Thomas MJ. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2561-5. PMID 23077142 DOI: 10.1161/Atvbaha.112.300135 |
0.067 |
|
| 2022 |
Bernhardt D, König L, Grosu A, Wiestler B, Rieken S, Wick W, Gempt J, Krieg SM, Schmidt-Graf F, Sahm F, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, et al. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 36038669 DOI: 10.1007/s00066-022-01994-3 |
0.066 |
|
| 2018 |
Christopoulos P, Chung I, Bozorgmehr F, Muley T, Meister M, Kobinger S, Marx A, Thomas M, Winter H, Herpel E, Rieker RJ, Fisch P, Grosch H. Deficient CD247 expression is a typical histopathologic characteristic of thymomas with cortical features. Histopathology. PMID 30079467 DOI: 10.1111/his.13724 |
0.066 |
|
| 2008 |
Bright E, Fishwick G, Berry D, Thomas M. Indwelling bowel management system as a cause of life-threatening rectal bleeding. Case Reports in Gastroenterology. 2: 351-5. PMID 21490868 DOI: 10.1159/000155147 |
0.066 |
|
| 2022 |
Hu XY, Oliver T, Willcox M, Simpson C, Thorne K, Trill J, Francis N, Stuart B, Thomas M, Little P, Liu JP, Griffiths G, Moore M. Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial. Pilot and Feasibility Studies. 8: 262. PMID 36536462 DOI: 10.1186/s40814-022-01224-8 |
0.066 |
|
| 2009 |
Coward SM, Legallais C, David B, Thomas M, Foo Y, Mavri-Damelin D, Hodgson HJ, Selden C. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artificial Organs. 33: 1117-26. PMID 20078562 DOI: 10.1111/J.1525-1594.2009.00821.X |
0.066 |
|
| 2011 |
Thomas MJ, Roddy E, Zhang W, Menz HB, Hannan MT, Peat GM. The population prevalence of foot and ankle pain in middle and old age: a systematic review. Pain. 152: 2870-80. PMID 22019150 DOI: 10.1016/j.pain.2011.09.019 |
0.066 |
|
| 2019 |
Leichsenring J, Horak P, Kreutzfeldt S, Heining C, Christopoulos P, Volckmar AL, Neumann O, Kirchner M, Ploeger C, Budczies J, Heilig CE, Hutter B, Fröhlich M, Uhrig S, Kazdal D, ... ... Thomas M, et al. Variant Classification in Precision Oncology. International Journal of Cancer. PMID 31008532 DOI: 10.1002/ijc.32358 |
0.066 |
|
| 2007 |
Ollinger R, Wang H, Yamashita K, Wegiel B, Thomas M, Margreiter R, Bach FH. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxidants & Redox Signaling. 9: 2175-85. PMID 17919067 DOI: 10.1089/ars.2007.1807 |
0.065 |
|
| 2002 |
Thomas M, Suwa T, Yang L, Zhao L, Hawks CL, Hornsby PJ. Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells. Neoplasia (New York, N.Y.). 4: 493-500. PMID 12407443 DOI: 10.1038/sj.neo.7900262 |
0.065 |
|
| 2018 |
Favari E, Thomas MJ, Sorci-Thomas MG. HDL Functionality As A New Pharmacological Target On CVD: Unifying Mechanism That Explains HDL Protection Towards The Progression Of Atherosclerosis. Journal of Cardiovascular Pharmacology. PMID 29528874 DOI: 10.1097/Fjc.0000000000000573 |
0.065 |
|
| 2003 |
Thomas M, Hawks CL, Hornsby PJ. Adrenocortical cell transplantation in scid mice: the role of the host animals' adrenal glands. The Journal of Steroid Biochemistry and Molecular Biology. 85: 285-90. PMID 12943714 |
0.065 |
|
| 2005 |
Keramidas M, Feige JJ, Thomas M. Coordinated regression of adrenocortical endocrine and endothelial compartments under adrenocorticotropin deprivation. Endocrine Research. 30: 543-9. PMID 15666790 DOI: 10.1081/erc-200043623 |
0.065 |
|
| 2010 |
Rocuts F, Zhang X, Yan J, Yue Y, Thomas M, Bach FH, Czismadia E, Wang H. Bilirubin promotes de novo generation of T regulatory cells. Cell Transplantation. 19: 443-51. PMID 20021735 DOI: 10.3727/096368909X484680 |
0.065 |
|
| 2021 |
Schulte-Vieting T, Siegle A, Jung C, Villalobos M, Thomas M. Developing a question prompt list for the oncology setting: A scoping review. Patient Education and Counseling. PMID 34686381 DOI: 10.1016/j.pec.2021.10.006 |
0.064 |
|
| 2013 |
Gu Z, Wu J, Wang S, Suburu J, Chen H, Thomas MJ, Shi L, Edwards IJ, Berquin IM, Chen YQ. Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells. Carcinogenesis. 34: 1968-75. PMID 23633519 DOI: 10.1093/Carcin/Bgt147 |
0.064 |
|
| 2012 |
Rothwell PE, Thomas MJ, Gewirtz JC. Protracted manifestations of acute dependence after a single morphine exposure. Psychopharmacology. 219: 991-8. PMID 21833504 DOI: 10.1007/s00213-011-2425-y |
0.064 |
|
| 2012 |
Kourrich S, Klug JR, Mayford M, Thomas MJ. AMPAR-independent effect of striatal αCaMKII promotes the sensitization of cocaine reward. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6578-86. PMID 22573680 DOI: 10.1523/JNEUROSCI.6391-11.2012 |
0.064 |
|
| 2007 |
Poole LB, Klomsiri C, Knaggs SA, Furdui CM, Nelson KJ, Thomas MJ, Fetrow JS, Daniel LW, King SB. Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins. Bioconjugate Chemistry. 18: 2004-17. PMID 18030992 DOI: 10.1021/Bc700257A |
0.064 |
|
| 2017 |
Brand S, Ko EJ, Viayna E, Thompson S, Spinks D, Thomas M, Sandberg L, Francisco AF, Jayawardhana S, Smith VC, Jansen C, De Rycker M, Thomas J, MacLean L, Osuna-Cabello M, et al. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi. Journal of Medicinal Chemistry. PMID 28844141 DOI: 10.1021/Acs.Jmedchem.7B00463 |
0.064 |
|
| 2011 |
Cook SC, Hadfield RJ, Thomas MJ. More evidence is required before we alter guidance on prognostication following cardiac arrest. Resuscitation. 82: 1105; author reply 1. PMID 21531494 DOI: 10.1016/j.resuscitation.2010.09.484 |
0.064 |
|
| 2019 |
Fletcher J, Tan ESL, Thomas M, Taylor F, Elliott D, Bindra R. Collagenase injections for Dupuytren's contracture: prospective cohort study in a public health setting. Anz Journal of Surgery. PMID 30685881 DOI: 10.1111/ans.14988 |
0.064 |
|
| 2014 |
Nakagawa K, Zingg JM, Kim SH, Thomas MJ, Dolnikowski GG, Azzi A, Miyazawa T, Meydani M. Differential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulation. The British Journal of Nutrition. 112: 8-14. PMID 24725345 DOI: 10.1017/S0007114514000567 |
0.064 |
|
| 2007 |
Robinson SN, Simmons PJ, Brouard N, Kidd S, Yang H, Decker WK, Xing D, Steiner D, Ng J, Thomas M, Champlin RE, de Lima M, Hosing CM, Cooper L, Singh H, et al. Efficacy of ‘Off-the-Shelf’, Commercially-Available, Third-Party Mesenchymal Stem Cells (MSC) in Ex Vivo Cord Blood (CB) Co-Culture Expansion. Blood. 110: 4106-4106. DOI: 10.1182/blood.V110.11.4106.4106 |
0.064 |
|
| 2014 |
Marks D, Bisset L, Thomas M, O'Leary S, Comans T, Ng SK, Conaghan PG, Scuffham P. An experienced physiotherapist prescribing and administering corticosteroid and local anaesthetic injections to the shoulder in an Australian orthopaedic service, a non-inferiority randomised controlled trial and economic analysis: study protocol for a randomised controlled trial. Trials. 15: 503. PMID 25527842 DOI: 10.1186/1745-6215-15-503 |
0.064 |
|
| 2011 |
Roddy E, Myers H, Thomas MJ, Marshall M, D'Cruz D, Menz HB, Belcher J, Muller S, Peat G. The clinical assessment study of the foot (CASF): study protocol for a prospective observational study of foot pain and foot osteoarthritis in the general population. Journal of Foot and Ankle Research. 4: 22. PMID 21892960 DOI: 10.1186/1757-1146-4-22 |
0.064 |
|
| 2018 |
Khandoga A, Thomas M, Kleespies A, Kühnke L, Andrassy J, Habicht A, Stangl M, Guba M, Angele M, Werner J, Rentsch M. Surgical complications and cardiovascular comorbidity - Substantial non-immunological confounders of survival after living donor kidney transplantation. The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. PMID 29861143 DOI: 10.1016/j.surge.2018.04.005 |
0.063 |
|
| 2016 |
Marks D, Comans T, Thomas M, Ng SK, O'Leary S, Conaghan PG, Scuffham PA, Bisset L. Agreement between a physiotherapist and an orthopaedic surgeon regarding management and prescription of corticosteroid injection for patients with shoulder pain. Manual Therapy. 26: 216-222. PMID 27744222 DOI: 10.1016/j.math.2016.10.001 |
0.063 |
|
| 2023 |
Cheng Y, Gaudy A, Liu L, Ye Y, Thomas M, Xue Y, Zhou S, Li Y. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Iberdomide. Clinical Pharmacology in Drug Development. PMID 37079714 DOI: 10.1002/cpdd.1254 |
0.063 |
|
| 2014 |
Thomas M, Corry B, Hilder TA. What have we learnt about the mechanisms of rapid water transport, ion rejection and selectivity in nanopores from molecular simulation? Small (Weinheim An Der Bergstrasse, Germany). 10: 1453-65. PMID 24851242 DOI: 10.1002/Smll.201302968 |
0.063 |
|
| 2014 |
Fede G, Spadaro L, Tomaselli T, Privitera G, Scicali R, Vasianopoulou P, Thalassinos E, Martin N, Thomas M, Purrello F, Burroughs AK. Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients With Stable Cirrhosis Clinical Gastroenterology and Hepatology. 12: 504-512. PMID 23978347 DOI: 10.1016/J.Cgh.2013.08.028 |
0.063 |
|
| 2005 |
Owen JS, Baker PR, O'Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL. Stress-induced platelet-activating factor synthesis in human neutrophils. Biochimica Et Biophysica Acta. 1733: 120-9. PMID 15863359 DOI: 10.1016/J.Bbalip.2004.12.016 |
0.063 |
|
| 2007 |
Kim HR, Chae HJ, Thomas M, Miyazaki T, Monosov A, Monosov E, Krajewska M, Krajewski S, Reed JC. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 188-96. PMID 17135360 DOI: 10.1096/fj.06-6283com |
0.063 |
|
| 2013 |
Sorci-Thomas MG, Thomas MJ. Why targeting HDL should work as a therapeutic tool, but has not. Journal of Cardiovascular Pharmacology. 62: 239-46. PMID 23743767 DOI: 10.1097/Fjc.0B013E31829D48A5 |
0.062 |
|
| 1999 |
Kemeny DM, Vyas B, Vukmanovic-Stejic M, Thomas MJ, Noble A, Loh LC, O'Connor BJ. CD8(+) T cell subsets and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 160: S33-7. PMID 10556167 DOI: 10.1164/ajrccm.160.supplement_1.10 |
0.062 |
|
| 2022 |
Syse A, Artamonova A, Thomas M, Veenstra M. Do characteristics of family members influence older persons' transition to long-term healthcare services? Bmc Health Services Research. 22: 362. PMID 35303891 DOI: 10.1186/s12913-022-07745-5 |
0.062 |
|
| 2015 |
Thomas MJ, Sorci-Thomas MG. SAA - A link between cholesterol efflux capacity and inflammation? Journal of Lipid Research. PMID 26078331 DOI: 10.1194/Jlr.C061366 |
0.062 |
|
| 2014 |
Hahn GL, Pado LE, Thomas MJ, Dunne JP. Certification Methodology to Transition Innovation (CMTI): Opportunities and lessons learned International Sampe Technical Conference. |
0.062 |
|
| 2022 |
Kohmer N, Rabenau HF, Ciesek S, Krämer BK, Göttmann U, Keller C, Rose D, Blume C, Thomas M, Lammert A, Lammert A. Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 35099023 DOI: 10.1093/ndt/gfac018 |
0.062 |
|
| 2022 |
Gaur R, Mensah KA, Stricker J, Adams M, Parton A, Cedzik D, Connarn J, Thomas M, Horan G, Schafer P, Mair S, Palmisano M, Ramírez-Valle F. CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production. Arthritis Research & Therapy. 24: 199. PMID 35982464 DOI: 10.1186/s13075-022-02850-6 |
0.062 |
|
| 2012 |
Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, et al. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis. 33: 404-12. PMID 22159221 DOI: 10.1093/Carcin/Bgr290 |
0.062 |
|
| 2020 |
Ouweneel AB, Thomas MJ, Sorci-Thomas MG. The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: Thematic Review Series: Biology of Lipid Rafts. Journal of Lipid Research. 61: 676-686. PMID 33715815 DOI: 10.1194/jlr.TR119000383 |
0.062 |
|
| 2013 |
O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ. Fatty acid metabolites in rapidly proliferating breast cancer. Plos One. 8: e63076. PMID 23658799 DOI: 10.1371/Journal.Pone.0063076 |
0.062 |
|
| 2008 |
Busse H, Thomas M, Seiwerts M, Moche M, Busse MW, von Salis-Soglio G, Kahn T. In vivo glenohumeral analysis using 3D MRI models and a flexible software tool: feasibility and precision. Journal of Magnetic Resonance Imaging : Jmri. 27: 162-70. PMID 18050335 DOI: 10.1002/jmri.21228 |
0.061 |
|
| 2023 |
Hollis D, Mendis MD, Ng SK, Thomas M, Marks D, Lewis J, Hides J, Bisset L. Are clinical outcomes associated with baseline sensory profiles in people with musculoskeletal shoulder pain? Protocol for a prospective longitudinal observational study. Musculoskeletal Care. PMID 37139704 DOI: 10.1002/msc.1770 |
0.061 |
|
| 2021 |
Zimmerman JAO, Fang M, Doumbia B, Neyman A, Cha JH, Thomas M, Hall B, Wu M, Wilson AM, Pufall MA. Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor. Rsc Medicinal Chemistry. 12: 203-212. PMID 34046609 DOI: 10.1039/d0md00278j |
0.061 |
|
| 2021 |
Schang C, Crosbie ND, Nolan M, Poon R, Wang M, Jex A, John N, Baker L, Scales P, Schmidt J, Thorley BR, Hill K, Zamyadi A, Tseng CW, Henry R, ... ... Thomas M, et al. Passive Sampling of SARS-CoV-2 for Wastewater Surveillance. Environmental Science & Technology. PMID 34264643 DOI: 10.1021/acs.est.1c01530 |
0.061 |
|
| 2020 |
Torrie LS, Robinson DA, Thomas M, Hobrath JV, Shepherd SM, Post JM, Ko EJ, Alves Ferreira RA, MacKenzie CJ, Wrobel K, Edwards D, Gilbert IH, Gray DW, Fairlamb AH, De Rycker M. Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase. Acs Infectious Diseases. PMID 32275825 DOI: 10.1021/acsinfecdis.9b00453 |
0.061 |
|
| 1991 |
Thomas MJ, Smith S, Pang JA. The use of water-soluble radical scavengers to detect hydroxyl radical formation by polymorphonuclear leukocytes. Free Radical Research Communications. 12: 53-7. PMID 1649103 DOI: 10.3109/10715769109145767 |
0.061 |
|
| 2016 |
Mgode GF, Mhamphi GG, Katkweba AS, Thomas M. Leptospira infections in freshwater fish in Morogoro Tanzania: a hidden public health threat. Tanzania Journal of Health Research. 16: 112-7. PMID 26875305 DOI: 10.4314/thrb.v16i2.7 |
0.061 |
|
| 1998 |
Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J. INFLAMMATORY MEDIATORS IN BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA IN LEUKOCYTOPENIC PATIENTS WITH SEPTIC SHOCK INDUCED ARDS Critical Care Medicine. 26: 126A. DOI: 10.1097/00003246-199801001-00375 |
0.061 |
|
| 2019 |
Gouk C, Ng SK, Knight M, Bindra R, Thomas M. Long term outcomes of open reduction internal fixation external fixation of distal radius fractures: A meta-analysis. Orthopedic Reviews. 11: 7809. PMID 31579208 DOI: 10.4081/or.2019.7809 |
0.061 |
|
| 1990 |
Robison TW, Thomas MJ, Samuel M, Forman HJ. Generation of aldehydes from rat alveolar macrophages exposed to nitrogen dioxide Free Radical Biology and Medicine. 9: 115. DOI: 10.1016/0891-5849(90)90586-8 |
0.061 |
|
| 2024 |
Cheng Y, Wang X, Liu L, Silva J, Thomas M, Li Y. A Phase I, Open-Label, Mass Balance Study of [C]-Iberdomide in Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. PMID 38521893 DOI: 10.1007/s13318-024-00886-4 |
0.06 |
|
| 2023 |
Thomas MJ, Nanagiri A, Duvidovich S, Levy L, Bamji N. Mission Disimpaction: Endoscopic Management of Stercoral Colitis in an Adolescent. Jpgn Reports. 4: e300. PMID 37200732 DOI: 10.1097/PG9.0000000000000300 |
0.06 |
|
| 2004 |
Chae HJ, Kim HR, Xu C, Bailly-Maitre B, Krajewska M, Krajewski S, Banares S, Cui J, Digicaylioglu M, Ke N, Kitada S, Monosov E, Thomas M, Kress CL, Babendure JR, et al. BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Molecular Cell. 15: 355-66. PMID 15304216 DOI: 10.1016/J.Molcel.2004.06.038 |
0.06 |
|
| 2022 |
Syse A, Thomas M, Dommermuth L, Hart RK. Does women's health matter for fertility? Evidence from Norwegian administrative data. Population Studies. 1-22. PMID 35255777 DOI: 10.1080/00324728.2022.2041075 |
0.06 |
|
| 2019 |
Wyllie S, Brand S, Thomas M, De Rycker M, Chung CW, Pena I, Bingham RP, Bueren-Calabuig JA, Cantizani J, Cebrian D, Craggs PD, Ferguson L, Goswami P, Hobrath J, Howe J, et al. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition. Proceedings of the National Academy of Sciences of the United States of America. PMID 30962368 DOI: 10.1073/Pnas.1820175116 |
0.06 |
|
| 2023 |
Montgomery A, Kasaniya M, Zhao P, Thomas M, Peterson K. The dam that fly ash built. Journal of Microscopy. PMID 37986607 DOI: 10.1111/jmi.13248 |
0.06 |
|
| 2000 |
Cefalu WT, Terry JG, Thomas MJ, Morgan TM, Edwards IJ, Rudel LL, Kemnitz JW, Weindruch R. In vitro oxidation of low-density lipoprotein in two species of nonhuman primates subjected to caloric restriction. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 55: B355-61. PMID 10898249 DOI: 10.1093/Gerona/55.7.B355 |
0.06 |
|
| 2016 |
Pollard RD, Fulp B, Sorci-Thomas MG, Thomas MJ. HDL Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation. Biochemistry. PMID 27501467 DOI: 10.1021/Acs.Biochem.6B00347 |
0.06 |
|
| 1994 |
Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Radical Biology & Medicine. 16: 339-46. PMID 8063197 DOI: 10.1016/0891-5849(94)90035-3 |
0.06 |
|
| 2018 |
Bösch F, Hofmann K, Coenen M, Pratschke S, Thomas M, Knösel T, Bruns CJ, Guba M, Werner J, Angele MK. Surgical treatment of pNET - Experience of a "high-volume" center. Surgical Oncology. 27: 409-414. PMID 30217295 DOI: 10.1016/j.suronc.2018.05.027 |
0.06 |
|
| 2012 |
Haire JC, Ferguson SA, Tilleard JD, Negus P, Dorrian J, Thomas MJ. Effect of working consecutive night shifts on sleep time, prior wakefulness, perceived levels of fatigue and performance on a psychometric test in emergency registrars. Emergency Medicine Australasia : Ema. 24: 251-9. PMID 22672165 DOI: 10.1111/j.1742-6723.2012.01533.x |
0.06 |
|
| 2018 |
Christopoulos P, Kirchner M, Endris V, Stenzinger A, Thomas M. V3, treatment resistance, and survival: refining the diagnosis of ALK NSCLC. Journal of Thoracic Disease. 10: S1989-S1991. PMID 30023099 DOI: 10.21037/jtd.2018.05.61 |
0.059 |
|
| 2020 |
Wahba R, Vitinius F, Walczuch B, Dieplinger G, Buchner D, Datta R, Lürssen N, Schlößer HA, Thomas M, Müller R, Kann M, Hellmich M, Kurschat C, Stippel DL. Hand-Assisted Retroperitoneoscopic Donor Nephrectomy Compared to Anterior Approach Open Donor Nephrectomy: Improved Long-Term Physical Component Score in Health-Related Quality of Life in Living Kidney Donors. Transplantation Proceedings. PMID 32981693 DOI: 10.1016/j.transproceed.2020.08.026 |
0.059 |
|
| 2015 |
Salomon A, Keramidas M, Maisin C, Thomas M. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition. Oncotarget. 6: 11421-33. PMID 25823656 |
0.059 |
|
| 2021 |
Guo W, Kim SH, Wu D, Li L, Ortega EF, Thomas M, Meydani SN, Meydani M. Dietary Fruit and Vegetable Supplementation Suppresses Diet-Induced Atherosclerosis in LDL Receptor Knockout Mice. The Journal of Nutrition. PMID 33561256 DOI: 10.1093/jn/nxaa410 |
0.059 |
|
| 2014 |
Heads SW, Thomas MJ, Wang Y. A remarkable new pygmy grasshopper (Orthoptera, Tetrigidae) in Miocene amber from the Dominican Republic. Zookeys. 87-100. PMID 25147472 DOI: 10.3897/Zookeys.429.8020 |
0.059 |
|
| 2015 |
Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, ... ... Thomas M, et al. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood. 125: 2885-92. PMID 25778529 DOI: 10.1182/Blood-2015-01-607366 |
0.058 |
|
| 2022 |
Rajakumar T, Horos R, Kittner P, Kahraman M, Sikosek T, Hinkfoth F, Tikk K, Mercaldo ND, Stenzinger A, Rabe KF, Reck M, Thomas M, Christopoulos P, Steinkraus BR. . Jto Clinical and Research Reports. 3: 100369. PMID 35880086 DOI: 10.1016/j.jtocrr.2022.100369 |
0.058 |
|
| 2020 |
Guo X, Smith V, Jackson M, Tran M, Thomas M, Patel A, Lorusso E, Nimbalkar S, Cai Y, McAleer CW, Wang Y, Long CJ, Hickman JJ. A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing. Advanced Therapeutics. 3. PMID 33709015 DOI: 10.1002/adtp.202000133 |
0.058 |
|
| 2005 |
Thomas SR, Wilson AJ, Chambler A, Harding I, Thomas M. Outcome of Copeland surface replacement shoulder arthroplasty. Journal of Shoulder and Elbow Surgery / American Shoulder and Elbow Surgeons ... [Et Al.]. 14: 485-91. PMID 16194739 DOI: 10.1016/j.jse.2005.02.011 |
0.058 |
|
| 2022 |
Aagaard NK, Malago M, De Gottardi A, Thomas M, Sauter G, Engelmann C, Aranovich D, Cohen M, Thévenot T, Ehmann T, Capel J, Angeli P, Jalan R, Stirnimann G. Consensus care recommendations for alfapump in cirrhotic patients with refractory or recurrent ascites. Bmc Gastroenterology. 22: 111. PMID 35260086 DOI: 10.1186/s12876-022-02173-5 |
0.058 |
|
| 2012 |
Herbet M, Salomon A, Feige JJ, Thomas M. Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes. Plos Genetics. 8: e1002700. PMID 22589739 DOI: 10.1371/journal.pgen.1002700 |
0.058 |
|
| 2016 |
Kaul S, Xu H, Zabalawi M, Maruko E, Fulp BE, Bluemn T, Brzoza-Lewis KL, Gerelus M, Weerasekera R, Kallinger R, James R, Zhang YS, Thomas MJ, Sorci-Thomas MG. Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio. Journal of the American Heart Association. 5. PMID 27821400 DOI: 10.1161/Jaha.116.004401 |
0.058 |
|
| 2002 |
Karmiloff-Smith A, Scerif G, Thomas M. Different approaches to relating genotype to phenotype in developmental disorders. Developmental Psychobiology. 40: 311-22. PMID 11891641 DOI: 10.1002/Dev.10035 |
0.058 |
|
| 2023 |
Solar S, Wieditz J, Lordick F, Mehnert-Theuerkauf A, Oechsle K, van Oorschot B, Thomas M, Asendorf T, Nauck F, Alt-Epping B. Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurability. Frontiers in Oncology. 13: 1002499. PMID 36776341 DOI: 10.3389/fonc.2023.1002499 |
0.058 |
|
| 2002 |
Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, Heindel W. Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers Radiology. 222: 773-781. PMID 11867800 |
0.058 |
|
| 2009 |
Sorci-Thomas MG, Bhat S, Thomas MJ. Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices. Clinical Lipidology. 4: 113-124. PMID 20582235 DOI: 10.2217/17584299.4.1.113 |
0.057 |
|
| 1987 |
Thomas MJ, Shirley PS, Hedrick CC, DeChatelet LR. Role of free radical processes in stimulated human polymorphonuclear leukocytes. Biochemistry. 25: 8042-8. PMID 3026467 DOI: 10.1021/Bi00372A037 |
0.057 |
|
| 2014 |
Suburu J, Shi L, Wu J, Wang S, Samuel M, Thomas MJ, Kock ND, Yang G, Kridel S, Chen YQ. Fatty acid synthase is required for mammary gland development and milk production during lactation. American Journal of Physiology. Endocrinology and Metabolism. 306: E1132-43. PMID 24668799 DOI: 10.1152/Ajpendo.00514.2013 |
0.057 |
|
| 2011 |
Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, Thomas MJ, Sorci-Thomas MG, Randolph GJ. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. The Journal of Clinical Investigation. 121: 2025-36. PMID 21505265 DOI: 10.1172/Jci43802 |
0.057 |
|
| 2014 |
Smith LN, Jedynak JP, Fontenot MR, Hale CF, Dietz KC, Taniguchi M, Thomas FS, Zirlin BC, Birnbaum SG, Huber KM, Thomas MJ, Cowan CW. Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration. Neuron. 82: 645-58. PMID 24811383 DOI: 10.1016/J.Neuron.2014.03.028 |
0.057 |
|
| 2018 |
Berendt J, Thomas M, Neukirchen M, Schwartz J, Hense J, Tewes M. [Integration of Palliative Care into the Comprehensive Cancer Center of Germany - Consultation Hours and Fellowship Rotations of the Specialized Palliative Care]. Deutsche Medizinische Wochenschrift (1946). 143: e139-e145. PMID 30134450 DOI: 10.1055/a-0626-9934 |
0.057 |
|
| 2019 |
Morshedi M, Boer SA, Thomas M, White NG. Easily-prepared Hydroxy-containing Receptors Recognize Anions in Aqueous Media. Chemistry, An Asian Journal. PMID 30747486 DOI: 10.1002/Asia.201900033 |
0.057 |
|
| 2022 |
Chiapponi C, Faust M, Schmidt M, Thomas M, Schultheis AM, Akgul B, Alakus H. Subacute thyroiditis after SARS-Cov2 vaccination: A review of the cases being described and personal experience. Endocrine Regulations. 56: 227-231. PMID 35843718 DOI: 10.2478/enr-2022-0024 |
0.057 |
|
| 2013 |
Thomas M, Mousa SS, Mousa SA. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration. Clinical Ophthalmology (Auckland, N.Z.). 7: 495-501. PMID 23503202 DOI: 10.2147/OPTH.S29974 |
0.057 |
|
| 2018 |
Webster LA, Thomas M, Urbaniak M, Wyllie S, Ong H, Tinti M, Fairlamb AH, Boesche M, Ghidelli-Disse S, Drewes G, Gilbert IH. Development of Chemical Proteomics for the Folateome and Analysis of the Kinetoplastid Folateome. Acs Infectious Diseases. PMID 30264983 DOI: 10.1021/acsinfecdis.8b00097 |
0.056 |
|
| 2007 |
McNulty C, Thomas M, John R, Lovering A, Lewis D, MacGowan A. Problems of basing patient recruitment for primary care studies on routine laboratory submissions. Journal of Clinical Pathology. 60: 1290-3. PMID 17337588 DOI: 10.1136/jcp.2007.046854 |
0.056 |
|
| 2021 |
Banner M, Alosert H, Spencer C, Cheeks M, Farid SS, Thomas M, Goldrick S. A decade in review: use of data analytics within the biopharmaceutical sector. Current Opinion in Chemical Engineering. 34: None. PMID 34926134 DOI: 10.1016/j.coche.2021.100758 |
0.056 |
|
| 2015 |
Brownson P, Donaldson O, Fox M, Rees JL, Rangan A, Jaggi A, Tytherleigh-Strong G, McBernie J, Thomas M, Kulkarni R. BESS/BOA Patient Care Pathways: Traumatic anterior shoulder instability. Shoulder & Elbow. 7: 214-26. PMID 27582981 DOI: 10.1177/1758573215585656 |
0.056 |
|
| 2015 |
Rathod T, Marshall M, Thomas MJ, Menz HB, Myers HL, Thomas E, Downes T, Peat G, Roddy E. Investigation of potential phenotypes of foot osteoarthritis: Cross-sectional analysis from the Clinical Assessment Study of the Foot. Arthritis Care & Research. PMID 26238801 DOI: 10.1002/acr.22677 |
0.056 |
|
| 2013 |
Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen SH, Thomas MJ, Kreisel D, Swartz MA, Sorci-Thomas MG, Randolph GJ. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. The Journal of Clinical Investigation. 123: 1571-9. PMID 23524964 DOI: 10.1172/Jci63685 |
0.056 |
|
| 2020 |
Guo W, Wu D, Dao MC, Li L, Lewis ED, Ortega EF, Eom H, Thomas M, Nikolova-Karakashian M, Meydani M, Meydani SN. A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice. The Journal of Nutrition. PMID 32939550 DOI: 10.1093/Jn/Nxaa259 |
0.056 |
|
| 2018 |
Hickey SM, Ashton TD, Boer G, Bader CA, Thomas M, Elliott AG, Schmuck C, Yu HY, Li J, Nation RL, Cooper MA, Plush SE, Brooks DA, Pfeffer FM. Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane. European Journal of Medicinal Chemistry. 160: 9-22. PMID 30316060 DOI: 10.1016/J.Ejmech.2018.09.072 |
0.056 |
|
| 2015 |
Thomas MJ, Battle RW. Something Old, Something New: Using Family History and Genetic Testing to Diagnose and Manage Athletes with Inherited Cardiovascular Disease. Clinics in Sports Medicine. 34: 517-37. PMID 26100426 DOI: 10.1016/j.csm.2015.03.006 |
0.055 |
|
| 2020 |
Wall RJ, Carvalho S, Milne R, Bueren-Calabuig JA, Moniz S, Cantizani-Perez J, MacLean L, Kessler A, Cotillo I, Sastry L, Manthri S, Patterson S, Zuccotto F, Thompson S, Martín JJ, ... ... Thomas M, et al. The Q site of cytochrome b is a promiscuous drug target in and . Acs Infectious Diseases. PMID 31967783 DOI: 10.1021/Acsinfecdis.9B00426 |
0.055 |
|
| 2021 |
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, ... ... Thomas M, et al. Symptom burden and palliative care needs of patients with incurable cancer at diagnosis and during the disease course. The Oncologist. PMID 33687742 DOI: 10.1002/onco.13751 |
0.055 |
|
| 2015 |
Costelloe SJ, Theocharidou E, Tsochatzis E, Thalassinos E, Martin N, Fede G, Thomas M, Burroughs AK. Hepascore and hyaluronic acid as markers of fibrosis in liver disease of mixed aetiology. European Journal of Gastroenterology & Hepatology. 27: 313-20. PMID 25563144 DOI: 10.1097/Meg.0000000000000267 |
0.055 |
|
| 2017 |
Wu X, Pfalzer AC, Koh GY, Tang S, Crott JW, Thomas MJ, Meydani M, Mason JB. Curcumin and Salsalate Suppresses Colonic Inflammation and Pro-Carcinogenic Signaling in High-Fat Fed, Azoxymethane-Treated Mice. Journal of Agricultural and Food Chemistry. PMID 28745498 DOI: 10.1021/acs.jafc.7b02648 |
0.055 |
|
| 2007 |
Kidd SM, Brouard N, Cao K, Robinson SN, Thomas M, Nguyen T, Qiao W, Thall P, Zweidler-McKay P, Shpall EJ, Simmons PJ. Manipulation of Oxygen Tension and Medium Composition To Enhance CD34+ Cell Numbers and Megakaryocytic Potential of Cord Blood Progenitors. Blood. 110: 772-772. DOI: 10.1182/blood.v110.11.772.772 |
0.055 |
|
| 2018 |
Huang LH, Zinselmeyer BH, Chang CH, Saunders BT, Elvington A, Baba O, Broekelmann TJ, Qi L, Rueve JS, Swartz MA, Kim BS, Mecham RP, Wiig H, Thomas MJ, Sorci-Thomas MG, et al. Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis. Cell Metabolism. PMID 30415924 DOI: 10.1016/J.Cmet.2018.10.006 |
0.055 |
|
| 2019 |
Bardia A, Gounder M, Rodon J, Janku F, Lolkema MP, Stephenson JJ, Bedard PL, Schuler M, Sessa C, LoRusso P, Thomas M, Maacke H, Evans H, Sun Y, Tan DSW. Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with Alterations. The Oncologist. PMID 31395751 DOI: 10.1634/theoncologist.2019-0297 |
0.055 |
|
| 2016 |
Thomas MJ, Creed RP, Skelton J, Brown BL. Ontogenetic shifts in a freshwater cleaning symbiosis: consequences for hosts and their symbionts. Ecology. 97: 1507-17. PMID 27459781 DOI: 10.1890/15-1443.1 |
0.055 |
|
| 2018 |
Corpas-Lopez V, Moniz S, Thomas M, Wall RJ, Torrie LS, Zander-Dinse D, Tinti M, Brand S, Stojanovski L, Manthri S, Hallyburton I, Zuccotto F, Wyatt PG, De Rycker M, Horn D, et al. Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani. Acs Infectious Diseases. PMID 30380837 DOI: 10.1021/Acsinfecdis.8B00226 |
0.055 |
|
| 2018 |
Wyllie S, Thomas M, Patterson S, Crouch S, De Rycker M, Lowe R, Gresham S, Urbaniak MD, Otto TD, Stojanovski L, Simeons FRC, Manthri S, MacLean LM, Zuccotto F, Homeyer N, et al. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Nature. PMID 30046105 DOI: 10.1038/S41586-018-0356-Z |
0.055 |
|
| 2011 |
Pust NJ, Dahlberg AR, Thomas MJ, Shaw JA. Comparison of full-sky polarization and radiance observations to radiative transfer simulations which employ AERONET products. Optics Express. 19: 18602-13. PMID 21935229 |
0.055 |
|
| 2024 |
Peterson NE, Thomas M, Hunsaker S, Stewart T, Collett CJ. mHealth Gratitude Exercise Mindfulness App for Resiliency Among Neonatal Intensive Care Unit Staff: Three-Arm Pretest-Posttest Interventional Study. Jmir Nursing. 7: e54561. PMID 38363595 DOI: 10.2196/54561 |
0.055 |
|
| 2010 |
Thomas MJ, Wood L, Selfe J, Peat G. Anterior knee pain in younger adults as a precursor to subsequent patellofemoral osteoarthritis: a systematic review. Bmc Musculoskeletal Disorders. 11: 201. PMID 20828401 DOI: 10.1186/1471-2474-11-201 |
0.054 |
|
| 2021 |
Thomas MJ, Dommermuth L. Interrelationships Among Fertility, Internal Migration,and Proximity to Nonresident Family: A Multilevel Multiprocess Analysis. Demography. PMID 34379118 DOI: 10.1215/00703370-9424636 |
0.054 |
|
| 2021 |
Le Mestre J, Thomas M, Duparc C, Val P, Bures C, Tuech JJ, Sabourin JC, Baert-Desurmont S, Lefebvre H, Louiset E. β-catenin activation and illicit receptor expression in adrenocortical cells. Endocrine-Related Cancer. PMID 34935630 DOI: 10.1530/ERC-21-0298 |
0.054 |
|
| 1998 |
Sorci-Thomas MG, Curtiss L, Parks JS, Thomas MJ, Kearns MW, Landrum M. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation. The Journal of Biological Chemistry. 273: 11776-82. PMID 9565601 DOI: 10.1074/Jbc.273.19.11776 |
0.054 |
|
| 2019 |
Egglestone A, Ingoe H, Rees J, Thomas M, Jeavons R, Rangan A. Scoping review: Diagnosis and management of periprosthetic joint infection in shoulder arthroplasty. Shoulder & Elbow. 11: 167-181. PMID 31210788 DOI: 10.1177/1758573218779076 |
0.054 |
|
| 2017 |
Christopoulos P, Thomas M. A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC. Journal of Thoracic Disease. 9: E292-E294. PMID 28449524 DOI: 10.21037/jtd.2017.02.86 |
0.054 |
|
| 2021 |
Little P, Francis NA, Stuart B, O'Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, ... ... Thomas M, et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet (London, England). PMID 34562391 DOI: 10.1016/S0140-6736(21)01431-8 |
0.054 |
|
| 2013 |
Pollard RD, Fulp B, Samuel MP, Sorci-Thomas MG, Thomas MJ. The conformation of lipid-free human apolipoprotein A-I in solution. Biochemistry. 52: 9470-81. PMID 24308268 DOI: 10.1021/Bi401080K |
0.054 |
|
| 2014 |
Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD, Wickman K. Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Proceedings of the National Academy of Sciences of the United States of America. 111: 10755-60. PMID 25002517 DOI: 10.1073/Pnas.1405190111 |
0.054 |
|
| 2024 |
Thomas M. Good news for 2024! Shoulder & Elbow. 16: 3. PMID 38435032 DOI: 10.1177/17585732231225429 |
0.054 |
|
| 2009 |
Keramidas M, Faudot C, Cibiel A, Feige JJ, Thomas M. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells. The Journal of Endocrinology. 196: 473-82. PMID 18310443 DOI: 10.1677/JOE-07-0255 |
0.053 |
|
| Hide low-probability matches. |